| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP100 ESR1 GRHL2 CREB1 STAT1 STAT3 PTPN2 GRHL1 BRD8 ARNT2 NFYB FOXP1 FKBP4 MED12 | 2.75e-06 | 582 | 107 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 2.96e-06 | 6 | 107 | 3 | GO:0070087 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.47e-05 | 58 | 107 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SP100 ESR1 CREB1 STAT1 STAT3 PTPN2 BRD8 ARNT2 FOXP1 FKBP4 MED12 | 1.48e-05 | 417 | 107 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription factor binding | SP100 ESR1 GRHL2 CREB1 STAT1 STAT3 PTPN2 GRHL1 BRD8 ARNT2 NFYB FOXP1 FKBP4 MED12 | 4.93e-05 | 753 | 107 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.69e-05 | 187 | 107 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.15e-04 | 18 | 107 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ATRX KIF1A SRP54 RNF213 ATP2C2 KIF19 NAV3 MACF1 ATP1A2 | 1.30e-04 | 441 | 107 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.69e-04 | 4 | 107 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 3.16e-04 | 25 | 107 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.21e-04 | 6 | 107 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B ATRX KIF1A ZGRF1 SRP54 RNF213 ATP2C2 KIF19 NAV3 MACF1 ATP1A2 | 4.56e-04 | 614 | 107 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.03e-04 | 31 | 107 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.26e-04 | 33 | 107 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.36e-03 | 308 | 107 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.50e-03 | 230 | 107 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 KIF13B ATRX KIF1A SEPTIN9 SRP54 RNF213 ATP2C2 KIF19 NAV3 MACF1 ATP1A2 | 1.78e-03 | 839 | 107 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 KIF13B ATRX KIF1A SEPTIN9 SRP54 RNF213 ATP2C2 KIF19 NAV3 MACF1 ATP1A2 | 1.80e-03 | 840 | 107 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 KIF13B ATRX KIF1A SEPTIN9 SRP54 RNF213 ATP2C2 KIF19 NAV3 MACF1 ATP1A2 | 1.80e-03 | 840 | 107 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | CCR5 chemokine receptor binding | 2.13e-03 | 13 | 107 | 2 | GO:0031730 | |
| GeneOntologyBiologicalProcess | central nervous system development | AHI1 GPR17 ATRX KIF1A SPTBN1 IKZF1 GRHL2 CREB1 DSCAML1 STAT3 SEMA3A FXR1 KCNA1 NF1 ARNT2 PLCB1 KDM2B FOXP1 ATP1A2 NIPBL MED12 | 5.43e-07 | 1197 | 105 | 21 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | AHI1 ATRX KIF1A PRICKLE1 IKZF1 GRHL2 CREB1 DSCAML1 SEMA3A FXR1 KCNA1 NF1 ARNT2 PLCB1 KDM2B FOXP1 ATP1A2 NIPBL | 8.36e-07 | 919 | 105 | 18 | GO:0060322 |
| GeneOntologyBiologicalProcess | brain development | AHI1 ATRX KIF1A IKZF1 GRHL2 CREB1 DSCAML1 SEMA3A FXR1 KCNA1 NF1 ARNT2 PLCB1 KDM2B FOXP1 ATP1A2 NIPBL | 1.53e-06 | 859 | 105 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | forebrain development | ATRX KIF1A IKZF1 CREB1 SEMA3A FXR1 KCNA1 NF1 PLCB1 KDM2B FOXP1 ATP1A2 | 7.30e-06 | 489 | 105 | 12 | GO:0030900 |
| GeneOntologyBiologicalProcess | embryo development | AHI1 PRICKLE1 VEZT HIPK1 GRHL2 DSCAML1 RYR2 UCMA SEMA3A PHLDB1 KIDINS220 NF1 ARNT2 PRICKLE2 PLCB1 KDM2B MACF1 FOXP1 NIPBL MED12 MYB | 9.73e-06 | 1437 | 105 | 21 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.66e-05 | 288 | 105 | 9 | GO:0045637 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SP100 MACC1 AHI1 ATRX ESR1 REL IKZF1 GRHL2 CREB1 STAT1 STAT3 ZNF462 GRHL1 BRD8 ARNT2 NFYB FOXP1 NIPBL MED12 MYB | 2.06e-05 | 1390 | 105 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | tube development | CLDN18 SP100 AHI1 ATRX PRICKLE1 HIPK1 ESR1 RNF213 GRHL2 CREB1 STAT1 STAT3 RYR2 NF1 KDM2B FOXP1 MME NIPBL MED12 MYB | 2.33e-05 | 1402 | 105 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | CLDN18 CD109 SRP54 IKZF1 CREB1 STAT1 STAT3 PTPN2 NF1 PLCB1 FOXP1 MYB | 2.71e-05 | 558 | 105 | 12 | GO:0030099 |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 3.11e-05 | 312 | 105 | 9 | GO:0002573 | |
| GeneOntologyBiologicalProcess | maintenance of location | SP100 ANK2 RNF213 RYR2 RYR3 ITPR2 PTPN2 PLCB1 ATP1A2 ARHGAP21 | 3.46e-05 | 396 | 105 | 10 | GO:0051235 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.68e-05 | 37 | 105 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 4.55e-05 | 39 | 105 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 5.41e-05 | 259 | 105 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | developmental growth | CLDN18 ATRX PRICKLE1 ESR1 IKZF1 GRHL2 CREB1 STAT3 SEMA3A ARIH2 PLCB1 MACF1 FOXP1 NIPBL MED12 | 5.73e-05 | 911 | 105 | 15 | GO:0048589 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | ESR1 CREB1 STAT1 STAT3 RYR2 RYR3 ITPR2 PLCB1 FOXP1 ATP1A2 FKBP4 SLC26A6 | 5.92e-05 | 605 | 105 | 12 | GO:0071407 |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 7.36e-05 | 44 | 105 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 7.68e-05 | 3 | 105 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B AHI1 KIF1A PRICKLE1 POTEKP INPP5F CLIP1 CREB1 DSCAML1 SEMA3A KCNA1 KIDINS220 NF1 LZTS1 PRICKLE2 MACF1 FOXP1 FKBP4 | 8.03e-05 | 1285 | 105 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 8.38e-05 | 204 | 105 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.03e-04 | 146 | 105 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.07e-04 | 147 | 105 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | CLDN18 SP100 GPR17 HIPK1 CREB1 STAT1 AKAP12 STAT3 PTPN2 NFYB PLCB1 FOXP1 MME SLC26A6 MYB | 1.12e-04 | 967 | 105 | 15 | GO:0071345 |
| GeneOntologyBiologicalProcess | response to cytokine | CLDN18 SP100 GPR17 HIPK1 REL CREB1 STAT1 AKAP12 STAT3 PTPN2 NFYB PLCB1 FOXP1 MME SLC26A6 MYB | 1.14e-04 | 1083 | 105 | 16 | GO:0034097 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.15e-04 | 149 | 105 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | cell junction organization | CLDN18 ANK2 KIF1A PRICKLE1 VEZT HIPK1 POTEKP GRHL2 SEMA3A GRHL1 NF1 LZTS1 PRICKLE2 MACF1 LIMCH1 | 1.21e-04 | 974 | 105 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.33e-04 | 153 | 105 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | embryonic organ development | AHI1 PRICKLE1 HIPK1 GRHL2 DSCAML1 RYR2 PRICKLE2 KDM2B NIPBL MED12 MYB | 1.35e-04 | 561 | 105 | 11 | GO:0048568 |
| GeneOntologyBiologicalProcess | response to peptide | CLDN18 SP100 GPR17 HIPK1 REL CREB1 STAT1 AKAP12 STAT3 PTPN2 NFYB PLCB1 FOXP1 MME SLC26A6 MYB | 1.36e-04 | 1100 | 105 | 16 | GO:1901652 |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 1.53e-04 | 4 | 105 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 1.53e-04 | 4 | 105 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | growth | CLDN18 AHI1 ATRX PRICKLE1 ESR1 IKZF1 GRHL2 CREB1 STAT3 SEMA3A ARIH2 PLCB1 KDM2B MACF1 FOXP1 NIPBL MED12 | 1.60e-04 | 1235 | 105 | 17 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.84e-04 | 22 | 105 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | sensory system development | AHI1 PRICKLE1 HIPK1 IKZF1 GRHL2 STAT3 SEMA3A NF1 KDM2B NIPBL | 2.04e-04 | 491 | 105 | 10 | GO:0048880 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.07e-04 | 166 | 105 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | myeloid cell homeostasis | 2.29e-04 | 240 | 105 | 7 | GO:0002262 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SP100 PRICKLE1 HIPK1 ESR1 ZMYM2 IKZF1 BCL7A CREB1 STAT1 STAT3 PTPN2 BEND6 MAGED2 PLCB1 KDM2B FOXP1 NIPBL MYB | 2.33e-04 | 1399 | 105 | 18 | GO:0045892 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.43e-04 | 171 | 105 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 2.54e-04 | 5 | 105 | 2 | GO:0098904 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SP100 PRICKLE1 HIPK1 ESR1 ZMYM2 IKZF1 BCL7A CREB1 STAT1 STAT3 PTPN2 BEND6 MAGED2 PLCB1 KDM2B FOXP1 NIPBL MYB | 2.63e-04 | 1413 | 105 | 18 | GO:1902679 |
| GeneOntologyBiologicalProcess | response to magnesium ion | 2.72e-04 | 25 | 105 | 3 | GO:0032026 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 2.72e-04 | 25 | 105 | 3 | GO:0051481 | |
| GeneOntologyBiologicalProcess | erythrocyte differentiation | 2.84e-04 | 176 | 105 | 6 | GO:0030218 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 2.86e-04 | 249 | 105 | 7 | GO:0035264 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | KIF13B AHI1 KIF1A INPP5F CLIP1 SEMA3A KIDINS220 NF1 LZTS1 MACF1 FKBP4 | 2.87e-04 | 612 | 105 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | telencephalon development | 2.98e-04 | 332 | 105 | 8 | GO:0021537 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | AHI1 PRICKLE1 ESR1 GRHL2 STAT1 RYR2 SEMA3A KDM2B FOXP1 CTNND1 MED12 | 3.16e-04 | 619 | 105 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | CLDN18 ESR1 STAT1 STAT3 PTPN2 BRD8 USO1 PLCB1 FOXP1 ATP1A2 FKBP4 SLC26A6 | 3.27e-04 | 727 | 105 | 12 | GO:0032870 |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 3.40e-04 | 182 | 105 | 6 | GO:0002761 | |
| GeneOntologyBiologicalProcess | type II interferon-mediated signaling pathway | 3.43e-04 | 27 | 105 | 3 | GO:0060333 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | KIF13B AHI1 KIF1A SEPTIN9 INPP5F CLIP1 TBC1D8 SEMA3A KIDINS220 NF1 LZTS1 MACF1 FKBP4 | 3.63e-04 | 846 | 105 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 3.80e-04 | 67 | 105 | 4 | GO:1900271 | |
| GeneOntologyBiologicalProcess | amygdala development | 3.80e-04 | 6 | 105 | 2 | GO:0021764 | |
| GeneOntologyBiologicalProcess | response to ionomycin | 3.80e-04 | 6 | 105 | 2 | GO:1904636 | |
| GeneOntologyBiologicalProcess | cellular response to ionomycin | 3.80e-04 | 6 | 105 | 2 | GO:1904637 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 3.83e-04 | 28 | 105 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | neuron development | KIF13B AHI1 KIF1A PRICKLE1 POTEKP INPP5F CLIP1 CREB1 DSCAML1 SEMA3A KCNA1 KIDINS220 NF1 LZTS1 PRICKLE2 MACF1 FOXP1 FKBP4 | 4.00e-04 | 1463 | 105 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | protein localization to organelle | SPATA7 CLDN18 SP100 AHI1 ANK2 ATRX PRICKLE1 ESR1 SRP54 STAT3 RYR2 NF1 ARIH2 MACF1 NIPBL | 4.10e-04 | 1091 | 105 | 15 | GO:0033365 |
| GeneOntologyBiologicalProcess | epithelium development | AHI1 ATRX PRICKLE1 ESR1 CD109 GRHL2 CREB1 STAT1 RYR2 SEMA3A GRHL1 NF1 ATP2C2 PLCB1 KDM2B FOXP1 CTNND1 MED12 | 4.20e-04 | 1469 | 105 | 18 | GO:0060429 |
| GeneOntologyBiologicalProcess | embryonic brain development | 4.25e-04 | 29 | 105 | 3 | GO:1990403 | |
| GeneOntologyBiologicalProcess | erythrocyte homeostasis | 4.27e-04 | 190 | 105 | 6 | GO:0034101 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 4.32e-04 | 351 | 105 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | AHI1 PRICKLE1 ESR1 GRHL2 STAT1 RYR2 SEMA3A KDM2B MACF1 FOXP1 CTNND1 MED12 | 4.32e-04 | 750 | 105 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | KIF13B AHI1 KIF1A SEPTIN9 INPP5F CLIP1 TBC1D8 SEMA3A KIDINS220 NF1 LZTS1 MACF1 FKBP4 | 4.38e-04 | 863 | 105 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | interleukin-9-mediated signaling pathway | 5.30e-04 | 7 | 105 | 2 | GO:0038113 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-9 | 5.30e-04 | 7 | 105 | 2 | GO:0071355 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA polymerase II transcription preinitiation complex assembly | 5.30e-04 | 7 | 105 | 2 | GO:0045899 | |
| GeneOntologyBiologicalProcess | gland development | 5.60e-04 | 558 | 105 | 10 | GO:0048732 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | SP100 AHI1 PRICKLE1 HIPK1 ESR1 RNF213 GRHL2 STAT1 STAT3 RYR2 NF1 KDM2B FOXP1 NIPBL MED12 | 5.65e-04 | 1125 | 105 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.26e-04 | 33 | 105 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 6.45e-04 | 77 | 105 | 4 | GO:0035567 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | AHI1 PRICKLE1 HIPK1 ESR1 IKZF1 GRHL2 DSCAML1 STAT1 STAT3 RYR2 SEMA3A NF1 KDM2B CTNND1 NIPBL MED12 | 6.70e-04 | 1269 | 105 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | cellular response to magnesium ion | 7.05e-04 | 8 | 105 | 2 | GO:0071286 | |
| GeneOntologyBiologicalProcess | response to interleukin-9 | 7.05e-04 | 8 | 105 | 2 | GO:0071104 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 7.45e-04 | 35 | 105 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | eye development | 7.75e-04 | 480 | 105 | 9 | GO:0001654 | |
| GeneOntologyBiologicalProcess | limbic system development | 7.76e-04 | 141 | 105 | 5 | GO:0021761 | |
| GeneOntologyBiologicalProcess | visual system development | 8.10e-04 | 483 | 105 | 9 | GO:0150063 | |
| GeneOntologyBiologicalProcess | response to hormone | CLDN18 ESR1 CREB1 STAT1 STAT3 PTPN2 BRD8 USO1 PLCB1 FOXP1 MME ATP1A2 FKBP4 SLC26A6 | 8.12e-04 | 1042 | 105 | 14 | GO:0009725 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 8.57e-04 | 217 | 105 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 8.57e-04 | 217 | 105 | 6 | GO:0030856 | |
| GeneOntologyBiologicalProcess | interleukin-2-mediated signaling pathway | 9.03e-04 | 9 | 105 | 2 | GO:0038110 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-2 | 9.03e-04 | 9 | 105 | 2 | GO:0071352 | |
| GeneOntologyBiologicalProcess | regulation of RNA polymerase II transcription preinitiation complex assembly | 9.03e-04 | 9 | 105 | 2 | GO:0045898 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 9.03e-04 | 9 | 105 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | axis elongation | 9.50e-04 | 38 | 105 | 3 | GO:0003401 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 9.65e-04 | 148 | 105 | 5 | GO:0048706 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | PRICKLE1 SEPTIN9 SPTBN1 IKZF1 PRRT2 CLIP1 CREB1 TBC1D8 PHLDB1 LZTS1 PRICKLE2 NAV3 MACF1 LIMCH1 FKBP4 | 9.95e-04 | 1189 | 105 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | AHI1 PRICKLE1 HIPK1 GRHL2 DSCAML1 RYR2 PHLDB1 KDM2B MACF1 NIPBL MED12 | 1.02e-03 | 713 | 105 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | glial cell proliferation | 1.02e-03 | 87 | 105 | 4 | GO:0014009 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.10e-03 | 40 | 105 | 3 | GO:0099558 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.12e-03 | 153 | 105 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 1.12e-03 | 10 | 105 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 1.12e-03 | 10 | 105 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum | 1.16e-03 | 90 | 105 | 4 | GO:0070972 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.16e-03 | 90 | 105 | 4 | GO:0060042 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ATRX PRICKLE1 SEPTIN9 ESR1 SPTBN1 PRRT2 BCL7A CLIP1 TBC1D8 PHLDB1 PRICKLE2 NAV3 PLCB1 LIMCH1 CDC27 FKBP4 | 1.21e-03 | 1342 | 105 | 16 | GO:0033043 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.24e-03 | 233 | 105 | 6 | GO:0061351 | |
| GeneOntologyBiologicalProcess | cellular response to tumor necrosis factor | 1.24e-03 | 233 | 105 | 6 | GO:0071356 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | KIF13B SP100 AHI1 KIF1A HIPK1 ESR1 STAT1 STAT3 SEMA3A PHLDB1 NF1 LZTS1 MACF1 FOXP1 | 1.25e-03 | 1090 | 105 | 14 | GO:0022603 |
| GeneOntologyCellularComponent | axon | KIF13B KIF1A PTBP2 ESR1 SPTBN1 POTEKP INPP5F PRRT2 CREB1 DSCAML1 STAT1 ITPR2 SEMA3A FXR1 KCNA1 NF1 MME CTNND1 FKBP4 | 1.19e-07 | 891 | 107 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 SP100 PTBP2 ORC3 REL BCL7A CREB1 TSEN2 STAT1 STAT3 BRD8 NFYB KDM2B BOD1L1 CDC27 NIPBL MED12 MYB XPO7 | 6.61e-05 | 1377 | 107 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 PRICKLE1 VEZT SPTBN1 PRRT2 STAT3 SEMA3A FXR1 KCNA1 NF1 LZTS1 PRICKLE2 PLCB1 CTNND1 | 7.25e-05 | 817 | 107 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | cell cortex | 1.23e-04 | 371 | 107 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | asymmetric synapse | ANK2 PRICKLE1 SPTBN1 PRRT2 STAT3 SEMA3A LZTS1 PRICKLE2 MACF1 CTNND1 | 1.70e-04 | 477 | 107 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | postsynapse | ANK2 KIF1A PRICKLE1 VEZT SPTBN1 PRRT2 STAT3 FXR1 KCNA1 LZTS1 PRICKLE2 PLCB1 MACF1 CTNND1 ATP1A2 | 2.10e-04 | 1018 | 107 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ANK2 PRICKLE1 SPTBN1 PRRT2 STAT3 SEMA3A LZTS1 PRICKLE2 MACF1 CTNND1 | 3.54e-04 | 523 | 107 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | chromatin | ATRX ORC3 ESR1 REL IKZF1 POTEKP BCL7A GRHL2 CREB1 STAT1 STAT3 GRHL1 BRD8 ARNT2 NFYB PLCB1 FOXP1 NIPBL | 4.96e-04 | 1480 | 107 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF1A PTBP2 ESR1 INPP5F PRRT2 STAT1 AKAP12 SEMA3A FXR1 KCNA1 NF1 LZTS1 MME CTNND1 ATP1A2 FKBP4 | 5.03e-04 | 1228 | 107 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic density | ANK2 PRICKLE1 SPTBN1 PRRT2 STAT3 LZTS1 PRICKLE2 MACF1 CTNND1 | 5.19e-04 | 451 | 107 | 9 | GO:0014069 |
| GeneOntologyCellularComponent | non-motile cilium | 5.19e-04 | 196 | 107 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 5.36e-04 | 7 | 107 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ANK2 PRICKLE1 SPTBN1 PRRT2 STAT3 LZTS1 PRICKLE2 MACF1 CTNND1 | 1.12e-03 | 503 | 107 | 9 | GO:0099572 |
| GeneOntologyCellularComponent | dendrite | KIF1A INPP5F PRRT2 STAT1 SEMA3A FXR1 KCNA1 NF1 LZTS1 MME CTNND1 ATP1A2 | 1.47e-03 | 858 | 107 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | KIF1A INPP5F PRRT2 STAT1 SEMA3A FXR1 KCNA1 NF1 LZTS1 MME CTNND1 ATP1A2 | 1.50e-03 | 860 | 107 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.58e-03 | 45 | 107 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | kinesin complex | 2.02e-03 | 49 | 107 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | nuclear envelope | 2.34e-03 | 560 | 107 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | A band | 2.40e-03 | 52 | 107 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.54e-03 | 360 | 107 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.55e-03 | 111 | 107 | 4 | GO:0001750 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B ANK2 KIF1A SEPTIN9 SPTBN1 POTEKP CLIP1 RYR2 RYR3 FXR1 KIF19 NAV3 MACF1 FKBP4 | 2.74e-03 | 1179 | 107 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B ANK2 KIF1A SEPTIN9 SPTBN1 POTEKP CLIP1 RYR2 RYR3 FXR1 KIF19 NAV3 MACF1 FKBP4 | 2.92e-03 | 1187 | 107 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | sarcolemma | 2.96e-03 | 190 | 107 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | paranode region of axon | 3.36e-03 | 17 | 107 | 2 | GO:0033270 | |
| MousePheno | lethality throughout fetal growth and development | SPTBN1 IKZF1 GRHL2 CREB1 RYR2 KIDINS220 NF1 ARIH2 KDM2B FOXP1 MYB | 5.61e-05 | 435 | 84 | 11 | MP:0006208 |
| MousePheno | postnatal lethality | AHI1 ANK2 KIF1A PRICKLE1 IKZF1 CREB1 DSCAML1 STAT3 RYR2 SEMA3A PTPN2 KCNA1 NF1 ARIH2 ARNT2 KIF19 PLCB1 NIPBL | 6.23e-05 | 1084 | 84 | 18 | MP:0002082 |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 7.22e-05 | 117 | 84 | 6 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 7.57e-05 | 118 | 84 | 6 | MP:0012349 | |
| MousePheno | disorganized myocardium | 9.40e-05 | 40 | 84 | 4 | MP:0002190 | |
| MousePheno | abnormal behavioral response to xenobiotic | PRICKLE1 PRRT2 SERPINA6 CREB1 RYR2 KCNA1 PRICKLE2 PLCB1 NIPBL | 9.64e-05 | 309 | 84 | 9 | MP:0009745 |
| MousePheno | abnormal excitatory synapse morphology | 1.11e-04 | 16 | 84 | 3 | MP:0020357 | |
| MousePheno | decreased B-1 B cell number | 1.24e-04 | 81 | 84 | 5 | MP:0004978 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 1.79e-04 | 263 | 84 | 8 | MP:0011099 | |
| MousePheno | abnormal reflex | KIF1A ESR1 ZMYM2 PRRT2 BCL7A GRHL2 STAT1 AKAP12 RYR2 ZNF462 PROKR1 PTPN2 KCNA1 BEND6 PLCB1 TTC17 ATP1A2 ACBD3 NIPBL | 1.93e-04 | 1294 | 84 | 19 | MP:0001961 |
| MousePheno | decreased paired-pulse ratio | 2.12e-04 | 4 | 84 | 2 | MP:0014253 | |
| MousePheno | abnormal seizure response to pharmacological agent | 2.53e-04 | 147 | 84 | 6 | MP:0000950 | |
| MousePheno | increased startle reflex | 2.81e-04 | 281 | 84 | 8 | MP:0001488 | |
| MousePheno | decreased single-positive T cell number | 2.84e-04 | 53 | 84 | 4 | MP:0008083 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | AHI1 ANK2 KIF1A IKZF1 CREB1 DSCAML1 STAT3 RYR2 SEMA3A PTPN2 KCNA1 ARIH2 ARNT2 KIF19 KDM2B FOXP1 NIPBL | 3.18e-04 | 1124 | 84 | 17 | MP:0011112 |
| MousePheno | abnormal erythroid progenitor cell morphology | 3.34e-04 | 100 | 84 | 5 | MP:0008801 | |
| Domain | RIH_assoc-dom | 3.71e-06 | 6 | 108 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.71e-06 | 6 | 108 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.71e-06 | 6 | 108 | 3 | PF08454 | |
| Domain | RIH_dom | 3.71e-06 | 6 | 108 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.71e-06 | 6 | 108 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.71e-06 | 6 | 108 | 3 | IPR015925 | |
| Domain | - | 3.71e-06 | 6 | 108 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.71e-06 | 6 | 108 | 3 | PF01365 | |
| Domain | MIR | 2.19e-05 | 10 | 108 | 3 | PF02815 | |
| Domain | MIR_motif | 2.19e-05 | 10 | 108 | 3 | IPR016093 | |
| Domain | MIR | 2.19e-05 | 10 | 108 | 3 | PS50919 | |
| Domain | MIR | 2.19e-05 | 10 | 108 | 3 | SM00472 | |
| Domain | FHA_DOMAIN | 2.95e-05 | 31 | 108 | 4 | PS50006 | |
| Domain | FHA | 2.95e-05 | 31 | 108 | 4 | PF00498 | |
| Domain | - | 5.40e-05 | 36 | 108 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 5.40e-05 | 36 | 108 | 4 | IPR000253 | |
| Domain | LIM3_prickle | 9.90e-05 | 3 | 108 | 2 | IPR033727 | |
| Domain | LIM2_prickle | 9.90e-05 | 3 | 108 | 2 | IPR033726 | |
| Domain | PET_prickle | 9.90e-05 | 3 | 108 | 2 | IPR033723 | |
| Domain | Ryanodine_rcpt | 9.90e-05 | 3 | 108 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 9.90e-05 | 3 | 108 | 2 | IPR009460 | |
| Domain | RyR | 9.90e-05 | 3 | 108 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 9.90e-05 | 3 | 108 | 2 | PF06459 | |
| Domain | Ryan_recept | 9.90e-05 | 3 | 108 | 2 | IPR013333 | |
| Domain | Kinesin-like_KIF1-typ | 1.97e-04 | 4 | 108 | 2 | IPR022140 | |
| Domain | KIF1B | 1.97e-04 | 4 | 108 | 2 | PF12423 | |
| Domain | SMAD_FHA_domain | 2.31e-04 | 52 | 108 | 4 | IPR008984 | |
| Domain | Kinesin_assoc | 4.89e-04 | 6 | 108 | 2 | PF16183 | |
| Domain | CP2 | 4.89e-04 | 6 | 108 | 2 | PF04516 | |
| Domain | CP2 | 4.89e-04 | 6 | 108 | 2 | IPR007604 | |
| Domain | Kinesin-like | 4.89e-04 | 6 | 108 | 2 | IPR022164 | |
| Domain | PET | 4.89e-04 | 6 | 108 | 2 | PF06297 | |
| Domain | PET_domain | 4.89e-04 | 6 | 108 | 2 | IPR010442 | |
| Domain | Kinesin_assoc | 4.89e-04 | 6 | 108 | 2 | IPR032405 | |
| Domain | PET | 4.89e-04 | 6 | 108 | 2 | PS51303 | |
| Domain | DUF3694 | 4.89e-04 | 6 | 108 | 2 | PF12473 | |
| Domain | CH | 5.46e-04 | 65 | 108 | 4 | SM00033 | |
| Domain | FHA | 5.54e-04 | 28 | 108 | 3 | SM00240 | |
| Domain | STAT_TF_DNA-bd_sub | 6.83e-04 | 7 | 108 | 2 | IPR012345 | |
| Domain | STAT | 6.83e-04 | 7 | 108 | 2 | IPR001217 | |
| Domain | STAT_int | 6.83e-04 | 7 | 108 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.83e-04 | 7 | 108 | 2 | IPR013801 | |
| Domain | STAT_bind | 6.83e-04 | 7 | 108 | 2 | PF02864 | |
| Domain | STAT_int | 6.83e-04 | 7 | 108 | 2 | PF02865 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.83e-04 | 7 | 108 | 2 | PF01017 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 6.83e-04 | 7 | 108 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 6.83e-04 | 7 | 108 | 2 | IPR015988 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 2.60.40.630 | |
| Domain | CH | 7.23e-04 | 70 | 108 | 4 | PF00307 | |
| Domain | - | 7.63e-04 | 71 | 108 | 4 | 1.10.418.10 | |
| Domain | ARM-type_fold | 7.91e-04 | 339 | 108 | 8 | IPR016024 | |
| Domain | - | 8.07e-04 | 261 | 108 | 7 | 1.10.238.10 | |
| Domain | CH | 8.47e-04 | 73 | 108 | 4 | PS50021 | |
| Domain | STAT_TF_alpha | 9.07e-04 | 8 | 108 | 2 | IPR013800 | |
| Domain | CH-domain | 9.37e-04 | 75 | 108 | 4 | IPR001715 | |
| Domain | EF-hand-dom_pair | 1.40e-03 | 287 | 108 | 7 | IPR011992 | |
| Domain | CAP_GLY | 1.45e-03 | 10 | 108 | 2 | PF01302 | |
| Domain | CAP_GLY | 1.45e-03 | 10 | 108 | 2 | SM01052 | |
| Domain | - | 1.45e-03 | 10 | 108 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 1.45e-03 | 10 | 108 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.45e-03 | 10 | 108 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.45e-03 | 10 | 108 | 2 | IPR000938 | |
| Domain | Kinesin_motor_CS | 1.71e-03 | 41 | 108 | 3 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.96e-03 | 43 | 108 | 3 | IPR027640 | |
| Domain | - | 2.10e-03 | 44 | 108 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.10e-03 | 44 | 108 | 3 | PF00225 | |
| Domain | KISc | 2.10e-03 | 44 | 108 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.10e-03 | 44 | 108 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.10e-03 | 44 | 108 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.10e-03 | 44 | 108 | 3 | PS50067 | |
| Domain | CRAL_TRIO_2 | 2.11e-03 | 12 | 108 | 2 | PF13716 | |
| Domain | ZU5 | 2.11e-03 | 12 | 108 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.11e-03 | 12 | 108 | 2 | IPR000906 | |
| Domain | SEA | 2.88e-03 | 14 | 108 | 2 | SM00200 | |
| Domain | - | 3.31e-03 | 15 | 108 | 2 | 3.30.70.960 | |
| Domain | p53-like_TF_DNA-bd | 3.57e-03 | 53 | 108 | 3 | IPR008967 | |
| Domain | ATPase_P-typ_TM_dom | 3.77e-03 | 16 | 108 | 2 | IPR023298 | |
| Domain | - | 3.77e-03 | 16 | 108 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.26e-03 | 17 | 108 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.26e-03 | 17 | 108 | 2 | PF00689 | |
| Domain | Ion_trans_dom | 4.33e-03 | 114 | 108 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.33e-03 | 114 | 108 | 4 | PF00520 | |
| Domain | Cation_ATPase_N | 4.77e-03 | 18 | 108 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 4.77e-03 | 18 | 108 | 2 | SM00831 | |
| Domain | ARM-like | 4.84e-03 | 270 | 108 | 6 | IPR011989 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.31e-03 | 19 | 108 | 2 | IPR004014 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.21e-05 | 130 | 84 | 7 | M27454 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.37e-05 | 103 | 84 | 6 | MM15196 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 5.59e-05 | 13 | 84 | 3 | M39589 | |
| Pathway | WP_LEPTIN_SIGNALING | 8.83e-05 | 76 | 84 | 5 | M39491 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | ESR1 SPTBN1 ZMYM2 RNF213 TFG CLIP1 CREB1 STAT1 STAT3 FXR1 NF1 | 9.27e-05 | 464 | 84 | 11 | M27547 |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.56e-04 | 18 | 84 | 3 | M673 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.85e-04 | 19 | 84 | 3 | M47760 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.05e-04 | 203 | 84 | 7 | M5485 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 2.96e-04 | 54 | 84 | 4 | M39435 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.96e-04 | 54 | 84 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.96e-04 | 54 | 84 | 4 | MM15202 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.49e-04 | 165 | 84 | 6 | MM15026 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATRX PTBP2 ORC3 SEPTIN9 SPTBN1 SRP54 EIF2D BRD8 NF1 MAGED2 USO1 MACF1 CTNND1 CDC27 NIPBL | 4.52e-10 | 582 | 109 | 15 | 20467437 |
| Pubmed | POGK HIPK1 SEPTIN9 PHLDB1 KIDINS220 RRP12 NAV3 MACF1 PPIP5K1 BOD1L1 LIMCH1 ARHGAP21 XPO7 | 5.41e-10 | 407 | 109 | 13 | 12693553 | |
| Pubmed | ANK2 SEPTIN9 SPTBN1 STAT1 AKAP12 STAT3 TBC1D8 KIDINS220 MAGED2 USO1 MACF1 BOD1L1 CTNND1 CDC27 ARHGAP21 MED12 | 7.59e-10 | 708 | 109 | 16 | 39231216 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 ATRX KIF1A VEZT PTBP2 SEPTIN9 MYRIP SRP54 RNF213 GRHL2 TSEN2 ZNF462 PHLDB1 KIDINS220 MACF1 FOXP1 TTC17 BOD1L1 LIMCH1 MME CTNND1 XPO7 | 1.15e-09 | 1489 | 109 | 22 | 28611215 |
| Pubmed | KIF13B ANK2 SPTBN1 ZMYM2 CLIP1 AKAP12 ZNF462 FXR1 KCNA1 NF1 MAGED2 LZTS1 PLCB1 MACF1 LIMCH1 CTNND1 NIPBL ARHGAP21 | 1.22e-09 | 963 | 109 | 18 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 ANK2 ATRX SEPTIN9 ZMYM2 SRP54 STAT1 AKAP12 STAT3 RRP12 MACF1 BOD1L1 CTNND1 ACBD3 NIPBL ARHGAP21 FKBP4 | 5.49e-09 | 934 | 109 | 17 | 33916271 |
| Pubmed | 9.99e-09 | 191 | 109 | 9 | 20195357 | ||
| Pubmed | 1.36e-08 | 268 | 109 | 10 | 33640491 | ||
| Pubmed | ANK2 ATRX KIF1A HIPK1 SPTBN1 MYRIP ZMYM2 DSCAML1 STAT1 STAT3 RYR3 ARIH2 NAV3 MACF1 TTC17 ATP1A2 ACBD3 NIPBL ARHGAP21 | 1.81e-08 | 1285 | 109 | 19 | 35914814 | |
| Pubmed | SART3 KIF13B SP100 MACC1 ANK2 ATRX PTBP2 SPTBN1 MYRIP REL RYR2 FXR1 MAGED2 MACF1 BOD1L1 LIMCH1 ATP1A2 CDC27 NIPBL ARHGAP21 | 2.10e-08 | 1442 | 109 | 20 | 35575683 | |
| Pubmed | KIAA0586 SRP54 TBC1D8 KIDINS220 MAGED2 USO1 MACF1 CTNND1 ARHGAP21 | 2.18e-08 | 209 | 109 | 9 | 36779422 | |
| Pubmed | Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. | 2.99e-08 | 3 | 109 | 3 | 30454647 | |
| Pubmed | SART3 MACC1 ATRX KIF1A ORC3 ESR1 ZMYM2 SRP54 BCL7A STAT1 BRD8 KIDINS220 SLC4A1AP RRP12 KDM2B MACF1 LIMCH1 CDC27 NIPBL MED12 | 3.89e-08 | 1497 | 109 | 20 | 31527615 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART3 ORC3 HIPK1 ZMYM2 REL CREB1 STAT1 STAT3 BRD8 FXR1 USO1 FOXP1 CTNND1 CDC27 XPO7 | 7.85e-08 | 857 | 109 | 15 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B SPTBN1 INPP5F CDC14A STAT3 PHLDB1 FXR1 NF1 USO1 MACF1 BOD1L1 LIMCH1 CTNND1 ARHGAP21 CCSER1 | 8.34e-08 | 861 | 109 | 15 | 36931259 |
| Pubmed | ATRX ESR1 SPTBN1 ZMYM2 REL BCL7A CREB1 STAT1 STAT3 ZNF462 BRD8 MAGED2 RRP12 NFYB KDM2B FOXP1 NIPBL FKBP4 MYB | 9.61e-08 | 1429 | 109 | 19 | 35140242 | |
| Pubmed | SART3 ATRX ORC3 SRP54 RNF213 STAT1 STAT3 PTPN2 BRD8 ARIH2 BOD1L1 CTNND1 NIPBL FKBP4 MED12 XPO7 | 1.14e-07 | 1014 | 109 | 16 | 32416067 | |
| Pubmed | Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A. | 1.20e-07 | 4 | 109 | 3 | 34812142 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX SEPTIN9 SPTBN1 ZMYM2 CLIP1 EIF2D BRD8 NF1 MAGED2 SLC4A1AP RRP12 KDM2B LIMCH1 NIPBL | 1.48e-07 | 774 | 109 | 14 | 15302935 |
| Pubmed | 2.80e-07 | 282 | 109 | 9 | 23667531 | ||
| Pubmed | MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers. | 2.98e-07 | 5 | 109 | 3 | 28649004 | |
| Pubmed | SART3 ANK2 SEPTIN9 SPTBN1 ITPR2 PHLDB1 FXR1 KCNA1 KIDINS220 NF1 USO1 LZTS1 PRICKLE2 MACF1 LIMCH1 CTNND1 ATP1A2 ARHGAP21 | 4.90e-07 | 1431 | 109 | 18 | 37142655 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SEPTIN9 SPTBN1 RYR3 PHLDB1 SLC4A1AP RRP12 KIF19 LIMCH1 CTNND1 ARHGAP21 MED12 | 4.95e-07 | 497 | 109 | 11 | 36774506 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SART3 SEPTIN9 INPP5F STAT1 FXR1 MAGED2 RRP12 MACF1 BOD1L1 ARHGAP21 FKBP4 | 5.05e-07 | 498 | 109 | 11 | 36634849 |
| Pubmed | VEZT RNF213 TFG ITPR2 FXR1 USO1 ARNT2 TTC17 BOD1L1 CTNND1 ACBD3 SLC26A6 YIPF3 | 5.32e-07 | 733 | 109 | 13 | 34672954 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.95e-07 | 6 | 109 | 3 | 25966694 | |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 20519450 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.95e-07 | 6 | 109 | 3 | 16844763 | |
| Pubmed | PRICKLE1 ORC3 ZMYM2 MUC16 RYR2 PHLDB1 NF1 LZTS1 NFYB PLCB1 KDM2B NIPBL | 8.14e-07 | 638 | 109 | 12 | 31182584 | |
| Pubmed | SART3 ANK2 ATRX VEZT SPTBN1 SRP54 AKAP12 ITPR2 TBC1D8 PTPN2 KIDINS220 SLC4A1AP RRP12 MACF1 TTC17 CTNND1 ACBD3 FKBP4 | 8.51e-07 | 1487 | 109 | 18 | 33957083 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 11860456 | ||
| Pubmed | 1.31e-06 | 60 | 109 | 5 | 19075228 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.33e-06 | 440 | 109 | 10 | 34244565 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 SP100 SEPTIN9 ZMYM2 SRP54 STAT1 STAT3 FXR1 MAGED2 SLC4A1AP | 1.44e-06 | 444 | 109 | 10 | 34795231 |
| Pubmed | 1.52e-06 | 27 | 109 | 4 | 26469385 | ||
| Pubmed | 1.57e-06 | 347 | 109 | 9 | 17114649 | ||
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 21747168 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.66e-06 | 8 | 109 | 3 | 19033399 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MACC1 SEPTIN9 SPTBN1 STAT1 KIDINS220 USO1 MACF1 LIMCH1 CTNND1 ACBD3 ARHGAP21 | 1.72e-06 | 565 | 109 | 11 | 25468996 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.84e-06 | 262 | 109 | 8 | 36880596 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 ATRX KIF1A SPTBN1 KIAA0586 TFG STAT1 FXR1 KIDINS220 NF1 MAGED2 USO1 RRP12 BOD1L1 CTNND1 NIPBL FKBP4 | 2.17e-06 | 1425 | 109 | 17 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 KIF13B POGK SEPTIN9 SRP54 PTPN2 FXR1 USO1 ARIH2 ATP1A2 NIPBL FKBP4 | 2.26e-06 | 704 | 109 | 12 | 29955894 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 SP100 PTBP2 ZGRF1 SEPTIN9 SPTBN1 CLIP1 MAGED2 SLC4A1AP MACF1 BOD1L1 NIPBL FKBP4 | 2.63e-06 | 847 | 109 | 13 | 35235311 |
| Pubmed | SART3 ANK2 VEZT SEPTIN9 SPTBN1 RYR2 PTPN2 KCNA1 NF1 PRICKLE2 NAV3 PLCB1 MACF1 CTNND1 ATP1A2 | 2.79e-06 | 1139 | 109 | 15 | 36417873 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 SART3 SP100 SPTBN1 TFG CLIP1 TSEN2 STAT1 AKAP12 STAT3 MAGED2 ARIH2 MACF1 LIMCH1 ACBD3 FKBP4 XPO7 | 2.87e-06 | 1455 | 109 | 17 | 22863883 |
| Pubmed | 3.21e-06 | 486 | 109 | 10 | 20936779 | ||
| Pubmed | 3.25e-06 | 283 | 109 | 8 | 21903422 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 SEPTIN9 SPTBN1 SRP54 STAT1 EIF2D PHLDB1 FXR1 NF1 MAGED2 RRP12 MACF1 CTNND1 CDC27 NIPBL MED12 | 4.98e-06 | 1353 | 109 | 16 | 29467282 |
| Pubmed | SPTBN1 PRRT2 KCNA1 TMEM132D NAV3 PLCB1 CTNND1 ATP1A2 ARHGAP21 | 5.51e-06 | 405 | 109 | 9 | 38187761 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 5.57e-06 | 37 | 109 | 4 | 27565344 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP100 ESR1 REL IKZF1 GRHL2 CREB1 STAT1 STAT3 GRHL1 ARNT2 NFYB FOXP1 MYB | 5.59e-06 | 908 | 109 | 13 | 19274049 |
| Pubmed | SPATA7 MUC16 RNF213 TFG AKAP12 RYR2 KIDINS220 MAGED2 USO1 CTNND1 ARHGAP21 XPO7 | 6.15e-06 | 777 | 109 | 12 | 35844135 | |
| Pubmed | 6.21e-06 | 38 | 109 | 4 | 28680062 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.35e-06 | 220 | 109 | 7 | 35785414 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.80e-06 | 313 | 109 | 8 | 38270169 | |
| Pubmed | SART3 KIF1A SPTBN1 FXR1 NF1 RRP12 MACF1 NIPBL FKBP4 MED12 XPO7 | 6.83e-06 | 653 | 109 | 11 | 22586326 | |
| Pubmed | 7.10e-06 | 418 | 109 | 9 | 34709266 | ||
| Pubmed | KIF13B AHI1 ATRX PTBP2 SPTBN1 SRP54 STAT1 AKAP12 BRD8 FXR1 MACF1 BOD1L1 CDC27 ARHGAP21 | 7.69e-06 | 1084 | 109 | 14 | 11544199 | |
| Pubmed | 8.37e-06 | 13 | 109 | 3 | 15882967 | ||
| Pubmed | ESR1 ZMYM2 GRHL2 STAT1 STAT3 ZNF462 GRHL1 BRD8 ARNT2 NFYB FOXP1 MYB | 9.11e-06 | 808 | 109 | 12 | 20412781 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 32357246 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12832402 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11579100 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18790697 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14978477 | ||
| Pubmed | Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. | 9.73e-06 | 2 | 109 | 2 | 21113126 | |
| Pubmed | Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes. | 9.73e-06 | 2 | 109 | 2 | 18692062 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30455249 | ||
| Pubmed | Targeting signal transducer and activator of transcription signaling pathway in leukemias. | 9.73e-06 | 2 | 109 | 2 | 19667270 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 23810008 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8898078 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26939627 | ||
| Pubmed | Identification of a nuclear Stat1 protein tyrosine phosphatase. | 9.73e-06 | 2 | 109 | 2 | 12138178 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 14550562 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 9.73e-06 | 2 | 109 | 2 | 26217001 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8654374 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12525887 | ||
| Pubmed | Mutations in prickle orthologs cause seizures in flies, mice, and humans. | 9.73e-06 | 2 | 109 | 2 | 21276947 | |
| Pubmed | Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer. | 9.73e-06 | 2 | 109 | 2 | 32142667 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30249887 | ||
| Pubmed | Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells. | 9.73e-06 | 2 | 109 | 2 | 11843291 | |
| Pubmed | Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma. | 9.73e-06 | 2 | 109 | 2 | 23756862 | |
| Pubmed | A phosphorylation-acetylation switch regulates STAT1 signaling. | 9.73e-06 | 2 | 109 | 2 | 19171783 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21376308 | ||
| Pubmed | TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers. | 9.73e-06 | 2 | 109 | 2 | 23166300 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 9.73e-06 | 2 | 109 | 2 | 21531043 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16678258 | ||
| Pubmed | Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling. | 9.73e-06 | 2 | 109 | 2 | 23950992 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16571725 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28158491 | ||
| Pubmed | STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription. | 9.73e-06 | 2 | 109 | 2 | 30134017 | |
| Pubmed | Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3. | 9.73e-06 | 2 | 109 | 2 | 29118089 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 24319264 | ||
| Pubmed | Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach. | 9.73e-06 | 2 | 109 | 2 | 31108008 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20568281 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12526039 | ||
| Pubmed | Novel interactions between ERα-36 and STAT3 mediate breast cancer cell migration. | 9.73e-06 | 2 | 109 | 2 | 31409371 | |
| Pubmed | Decreased levels of both Stat1 and Stat3 in T lymphocytes from mice bearing mammary tumors. | 9.73e-06 | 2 | 109 | 2 | 19528464 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15161711 | ||
| Interaction | AR interactions | SART3 ATRX KIF1A ESR1 ZMYM2 RNF213 REL BCL7A GRHL2 CREB1 STAT3 ZNF462 GRHL1 BRD8 FXR1 KDM2B FOXP1 LIMCH1 MME CDC27 NIPBL FKBP4 MED12 | 2.16e-09 | 992 | 108 | 23 | int:AR |
| Interaction | PML interactions | SART3 SP100 ATRX HIPK1 SEPTIN9 CD109 ZMYM2 SRP54 RNF213 STAT1 STAT3 ITPR2 BRD8 FXR1 NF1 MAGED2 SLC4A1AP USO1 RRP12 ARIH2 MYB | 2.02e-08 | 933 | 108 | 21 | int:PML |
| Interaction | KCNA3 interactions | ANK2 SEPTIN9 SPTBN1 RNF213 PRRT2 CLIP1 STAT1 AKAP12 STAT3 TBC1D8 KCNA1 KIDINS220 MAGED2 USO1 MACF1 BOD1L1 CTNND1 CDC27 ARHGAP21 MED12 | 3.34e-08 | 871 | 108 | 20 | int:KCNA3 |
| Interaction | SOX2 interactions | SART3 PTBP2 SPTBN1 ZMYM2 SRP54 BCL7A CREB1 ITPR2 ZNF462 BRD8 KIDINS220 MAGED2 LZTS1 RRP12 PRICKLE2 NAV3 KDM2B MACF1 FOXP1 BOD1L1 CTNND1 NIPBL ARHGAP21 FKBP4 | 3.87e-07 | 1422 | 108 | 24 | int:SOX2 |
| Interaction | GSK3A interactions | PTBP2 KIAA0586 SRP54 CREB1 STAT1 TBC1D8 FXR1 KIDINS220 MAGED2 USO1 MACF1 CTNND1 ARHGAP21 | 1.22e-06 | 464 | 108 | 13 | int:GSK3A |
| Interaction | CDC5L interactions | PTBP2 ORC3 SEPTIN9 ESR1 SPTBN1 SRP54 CDC14A EIF2D BRD8 FXR1 NF1 USO1 MACF1 FOXP1 CTNND1 CDC27 NIPBL | 2.92e-06 | 855 | 108 | 17 | int:CDC5L |
| Interaction | DSCAM interactions | 3.90e-06 | 171 | 108 | 8 | int:DSCAM | |
| Interaction | NAA40 interactions | SART3 ANK2 ATRX SEPTIN9 ZMYM2 SRP54 STAT1 AKAP12 STAT3 RRP12 MACF1 BOD1L1 LIMCH1 CTNND1 ACBD3 NIPBL ARHGAP21 FKBP4 | 4.25e-06 | 978 | 108 | 18 | int:NAA40 |
| Interaction | IRF4 interactions | 6.39e-06 | 85 | 108 | 6 | int:IRF4 | |
| Interaction | LYN interactions | PRUNE2 ANK2 SEPTIN9 SPTBN1 AKAP12 STAT3 TBC1D8 KIDINS220 NF1 NFYB PLCB1 MACF1 MME CTNND1 ARHGAP21 | 6.83e-06 | 720 | 108 | 15 | int:LYN |
| Interaction | LCK interactions | ESR1 SPTBN1 STAT1 STAT3 KIDINS220 NF1 USO1 MACF1 CTNND1 ACBD3 ARHGAP21 FKBP4 | 7.12e-06 | 463 | 108 | 12 | int:LCK |
| Interaction | CAV1 interactions | KIF13B SEPTIN9 ESR1 SPTBN1 AKAP12 TBC1D8 KIDINS220 NF1 USO1 RRP12 MACF1 CTNND1 ACBD3 ARHGAP21 YIPF3 | 7.30e-06 | 724 | 108 | 15 | int:CAV1 |
| Interaction | WEE1 interactions | 7.46e-06 | 133 | 108 | 7 | int:WEE1 | |
| Interaction | FOXQ1 interactions | 1.09e-05 | 141 | 108 | 7 | int:FOXQ1 | |
| Interaction | LAMP3 interactions | KIF1A VEZT SPTBN1 RNF213 INPP5F AKAP12 ITPR2 TBC1D8 KIDINS220 CTNND1 ACBD3 SLC26A6 | 1.16e-05 | 486 | 108 | 12 | int:LAMP3 |
| Interaction | OCLN interactions | ANK2 SPTBN1 AKAP12 TBC1D8 PTPN2 PHLDB1 KIDINS220 MACF1 CTNND1 ACBD3 ARHGAP21 CCSER1 | 1.54e-05 | 500 | 108 | 12 | int:OCLN |
| Interaction | HNF4A interactions | 1.73e-05 | 275 | 108 | 9 | int:HNF4A | |
| Interaction | CREBBP interactions | SP100 ATRX HIPK1 ESR1 ZMYM2 REL CREB1 STAT1 STAT3 ARNT2 NFYB CDC27 MYB | 1.93e-05 | 599 | 108 | 13 | int:CREBBP |
| Interaction | MAPRE1 interactions | KIF1A VEZT SEPTIN9 SPTBN1 CD109 SRP54 CLIP1 FXR1 NAV3 MACF1 ARHGAP21 CCSER1 | 2.02e-05 | 514 | 108 | 12 | int:MAPRE1 |
| Interaction | CRTC1 interactions | 2.20e-05 | 31 | 108 | 4 | int:CRTC1 | |
| Interaction | KAT5 interactions | 2.28e-05 | 358 | 108 | 10 | int:KAT5 | |
| Interaction | STX6 interactions | VEZT ESR1 SPTBN1 PRRT2 AKAP12 KIDINS220 USO1 MACF1 CTNND1 ACBD3 ARHGAP21 | 2.88e-05 | 448 | 108 | 11 | int:STX6 |
| Interaction | STARD13 interactions | 3.21e-05 | 68 | 108 | 5 | int:STARD13 | |
| Interaction | GJD3 interactions | VEZT SPTBN1 SRP54 ITPR2 TBC1D8 PTPN2 KIDINS220 USO1 CTNND1 ACBD3 YIPF3 | 3.25e-05 | 454 | 108 | 11 | int:GJD3 |
| Interaction | FBXO22 interactions | SEPTIN9 ESR1 SPTBN1 RYR3 PHLDB1 SLC4A1AP RRP12 KIF19 LIMCH1 CTNND1 ARHGAP21 MED12 | 3.27e-05 | 540 | 108 | 12 | int:FBXO22 |
| Interaction | MAPRE3 interactions | 3.37e-05 | 230 | 108 | 8 | int:MAPRE3 | |
| Interaction | TNIK interactions | ANK2 SPTBN1 ZMYM2 ZNF462 FXR1 MAGED2 LZTS1 MACF1 CTNND1 ARHGAP21 | 3.87e-05 | 381 | 108 | 10 | int:TNIK |
| Interaction | DLK2 interactions | 4.03e-05 | 36 | 108 | 4 | int:DLK2 | |
| Interaction | DYRK1A interactions | KIF1A SEPTIN9 ESR1 SPTBN1 CREB1 DSCAML1 NF1 LZTS1 LIMCH1 CTNND1 CDC27 XPO7 | 4.05e-05 | 552 | 108 | 12 | int:DYRK1A |
| Interaction | CBX3 interactions | SP100 ATRX ORC3 POGK ESR1 ZMYM2 IKZF1 ZNF462 SLC4A1AP KDM2B MACF1 NIPBL FKBP4 | 4.21e-05 | 646 | 108 | 13 | int:CBX3 |
| Interaction | KIF20A interactions | ANK2 KIF1A PTBP2 SPTBN1 CD109 POTEKP CDC14A ITPR2 ZNF462 FXR1 KIDINS220 LZTS1 NAV3 MACF1 PPIP5K1 BOD1L1 CTNND1 | 4.29e-05 | 1052 | 108 | 17 | int:KIF20A |
| Interaction | HDAC4 interactions | KIF13B ATRX KIF1A SEPTIN9 ESR1 SPTBN1 IKZF1 CREB1 STAT1 FXR1 NF1 NAV3 PLCB1 LIMCH1 | 4.35e-05 | 744 | 108 | 14 | int:HDAC4 |
| Interaction | PLEKHA7 interactions | 4.38e-05 | 119 | 108 | 6 | int:PLEKHA7 | |
| Interaction | FLOT1 interactions | ANK2 SEPTIN9 SPTBN1 AKAP12 TBC1D8 KIDINS220 NF1 MACF1 BOD1L1 CTNND1 ARHGAP21 | 4.90e-05 | 475 | 108 | 11 | int:FLOT1 |
| Interaction | NANOG interactions | ZMYM2 MUC16 REL GRHL2 CLIP1 ZNF462 BRD8 FXR1 RRP12 KDM2B MED12 | 5.49e-05 | 481 | 108 | 11 | int:NANOG |
| Interaction | CDH1 interactions | MACC1 VEZT SEPTIN9 SPTBN1 STAT1 STAT3 KIDINS220 USO1 MACF1 LIMCH1 CTNND1 CDC27 ACBD3 ARHGAP21 | 6.13e-05 | 768 | 108 | 14 | int:CDH1 |
| Interaction | DCTN1 interactions | AHI1 SPTBN1 CLIP1 STAT1 FXR1 NF1 USO1 MACF1 CDC27 ACBD3 ARHGAP21 | 7.35e-05 | 497 | 108 | 11 | int:DCTN1 |
| Interaction | DIRAS3 interactions | 8.42e-05 | 262 | 108 | 8 | int:DIRAS3 | |
| Interaction | PFN1 interactions | ANK2 SEPTIN9 ESR1 SPTBN1 INPP5F KIDINS220 NF1 MACF1 BOD1L1 LIMCH1 ARHGAP21 | 9.09e-05 | 509 | 108 | 11 | int:PFN1 |
| Interaction | CTNNB1 interactions | ANK2 VEZT ESR1 PRRT2 CREB1 STAT1 AKAP12 FXR1 USO1 NFYB FOXP1 LIMCH1 CTNND1 CDC27 ARHGAP21 FKBP4 | 9.22e-05 | 1009 | 108 | 16 | int:CTNNB1 |
| Interaction | CTNNA1 interactions | VEZT SPTBN1 FXR1 KIDINS220 MAGED2 MACF1 CTNND1 ARHGAP21 XPO7 | 1.05e-04 | 347 | 108 | 9 | int:CTNNA1 |
| Interaction | BRCA1 interactions | SART3 ORC3 SEPTIN9 ESR1 SPTBN1 TFG CLIP1 CREB1 STAT1 AKAP12 STAT3 NF1 USO1 CDC27 NIPBL ARHGAP21 FKBP4 MED12 | 1.09e-04 | 1249 | 108 | 18 | int:BRCA1 |
| Interaction | FEV interactions | 1.12e-04 | 203 | 108 | 7 | int:FEV | |
| Interaction | GRIA2 interactions | 1.12e-04 | 203 | 108 | 7 | int:GRIA2 | |
| Interaction | MEN1 interactions | SART3 KIF13B ATRX ESR1 ZMYM2 RNF213 GRHL2 ITPR2 ZNF462 FXR1 RRP12 FOXP1 BOD1L1 CTNND1 MED12 MYB | 1.16e-04 | 1029 | 108 | 16 | int:MEN1 |
| Interaction | SNCA interactions | SART3 SEPTIN9 SPTBN1 INPP5F STAT1 FXR1 MAGED2 RRP12 PLCB1 MACF1 CTNND1 ARHGAP21 FKBP4 | 1.19e-04 | 716 | 108 | 13 | int:SNCA |
| Interaction | MYCBP2 interactions | 1.25e-04 | 355 | 108 | 9 | int:MYCBP2 | |
| Interaction | RAB11A interactions | KIF13B VEZT ESR1 SPTBN1 INPP5F AKAP12 ITPR2 TBC1D8 KIDINS220 USO1 RRP12 MME CTNND1 ACBD3 | 1.39e-04 | 830 | 108 | 14 | int:RAB11A |
| Interaction | DNAJC1 interactions | 1.42e-04 | 361 | 108 | 9 | int:DNAJC1 | |
| Interaction | KDM1A interactions | ZGRF1 ESR1 ZMYM2 IKZF1 INPP5F STAT3 ZNF462 SLC4A1AP USO1 LZTS1 KDM2B FOXP1 ARHGAP21 FKBP4 MED12 | 1.47e-04 | 941 | 108 | 15 | int:KDM1A |
| Interaction | PIAS3 interactions | 1.59e-04 | 95 | 108 | 5 | int:PIAS3 | |
| Interaction | PRKAR2A interactions | 1.69e-04 | 217 | 108 | 7 | int:PRKAR2A | |
| Interaction | CSNK2A1 interactions | SART3 ATRX ESR1 SPTBN1 REL CREB1 EIF2D FXR1 SLC4A1AP RRP12 KDM2B MACF1 MME FKBP4 MYB | 1.75e-04 | 956 | 108 | 15 | int:CSNK2A1 |
| Interaction | KHDRBS1 interactions | 1.81e-04 | 373 | 108 | 9 | int:KHDRBS1 | |
| Interaction | UBE2I interactions | SP100 HIPK1 ESR1 ZMYM2 IKZF1 TFG CLIP1 CREB1 STAT1 STAT3 MYB XPO7 | 2.00e-04 | 654 | 108 | 12 | int:UBE2I |
| Interaction | NR3C1 interactions | PRICKLE1 ORC3 ZMYM2 MUC16 CREB1 STAT3 RYR2 PHLDB1 NF1 LZTS1 NFYB PLCB1 KDM2B NIPBL FKBP4 | 2.14e-04 | 974 | 108 | 15 | int:NR3C1 |
| Interaction | BMI1 interactions | SART3 ATRX PTBP2 SPTBN1 RYR3 ITPR2 FXR1 RRP12 KDM2B CTNND1 MED12 MYB | 2.15e-04 | 659 | 108 | 12 | int:BMI1 |
| Interaction | ZBTB21 interactions | 2.32e-04 | 161 | 108 | 6 | int:ZBTB21 | |
| Interaction | DAB2IP interactions | 2.32e-04 | 103 | 108 | 5 | int:DAB2IP | |
| Interaction | RAB35 interactions | VEZT SPTBN1 INPP5F AKAP12 KIDINS220 PLCB1 MACF1 CTNND1 ACBD3 ARHGAP21 SLC26A6 | 2.55e-04 | 573 | 108 | 11 | int:RAB35 |
| Interaction | CEP120 interactions | 2.66e-04 | 106 | 108 | 5 | int:CEP120 | |
| Interaction | C11orf52 interactions | 2.72e-04 | 311 | 108 | 8 | int:C11orf52 | |
| Interaction | CNTN2 interactions | 2.79e-04 | 24 | 108 | 3 | int:CNTN2 | |
| Interaction | TRIM28 interactions | SART3 KIF13B ATRX POGK SEPTIN9 ESR1 SRP54 IKZF1 STAT1 STAT3 ZNF462 PTPN2 FXR1 USO1 ARIH2 ATP1A2 NIPBL FKBP4 MYB | 2.92e-04 | 1474 | 108 | 19 | int:TRIM28 |
| Interaction | GJA1 interactions | GPR17 VEZT SPTBN1 ITPR2 TBC1D8 KIDINS220 USO1 MACF1 CTNND1 ACBD3 ARHGAP21 | 2.95e-04 | 583 | 108 | 11 | int:GJA1 |
| Interaction | GRHL2 interactions | 3.16e-04 | 25 | 108 | 3 | int:GRHL2 | |
| Interaction | TSPOAP1 interactions | 3.16e-04 | 25 | 108 | 3 | int:TSPOAP1 | |
| Interaction | PCNT interactions | 3.21e-04 | 241 | 108 | 7 | int:PCNT | |
| Interaction | CTBP1 interactions | 3.38e-04 | 406 | 108 | 9 | int:CTBP1 | |
| Interaction | TRIM11 interactions | 3.41e-04 | 173 | 108 | 6 | int:TRIM11 | |
| Interaction | SEPTIN5 interactions | 3.43e-04 | 62 | 108 | 4 | int:SEPTIN5 | |
| Interaction | TAF6 interactions | 3.54e-04 | 245 | 108 | 7 | int:TAF6 | |
| Interaction | TLX1 interactions | 3.62e-04 | 175 | 108 | 6 | int:TLX1 | |
| Interaction | NRAS interactions | KIF13B VEZT SEPTIN9 ESR1 SPTBN1 AKAP12 PHLDB1 KIDINS220 NF1 PLCB1 MACF1 CTNND1 | 3.67e-04 | 699 | 108 | 12 | int:NRAS |
| Interaction | TEAD1 interactions | 3.73e-04 | 176 | 108 | 6 | int:TEAD1 | |
| Interaction | FGD4 interactions | 3.87e-04 | 64 | 108 | 4 | int:FGD4 | |
| Interaction | DBN1 interactions | 4.10e-04 | 417 | 108 | 9 | int:DBN1 | |
| Interaction | ACOT8 interactions | 4.11e-04 | 65 | 108 | 4 | int:ACOT8 | |
| Interaction | PIAS2 interactions | 4.21e-04 | 180 | 108 | 6 | int:PIAS2 | |
| Interaction | FAM106A interactions | 4.21e-04 | 6 | 108 | 2 | int:FAM106A | |
| Interaction | GRHL1 interactions | 4.21e-04 | 6 | 108 | 2 | int:GRHL1 | |
| Interaction | LAMP2 interactions | KIF1A VEZT ESR1 SPTBN1 INPP5F AKAP12 TBC1D8 KIDINS220 PLCB1 CTNND1 ACBD3 | 4.27e-04 | 609 | 108 | 11 | int:LAMP2 |
| Interaction | AFDN interactions | 4.29e-04 | 333 | 108 | 8 | int:AFDN | |
| Interaction | CRX interactions | 4.40e-04 | 254 | 108 | 7 | int:CRX | |
| Interaction | SKIL interactions | 4.53e-04 | 119 | 108 | 5 | int:SKIL | |
| Interaction | ESRRA interactions | 4.61e-04 | 67 | 108 | 4 | int:ESRRA | |
| Interaction | TDG interactions | 5.16e-04 | 69 | 108 | 4 | int:TDG | |
| Interaction | FOXP3 interactions | 5.29e-04 | 432 | 108 | 9 | int:FOXP3 | |
| Interaction | KIF9 interactions | 5.45e-04 | 70 | 108 | 4 | int:KIF9 | |
| Interaction | SIRT6 interactions | SART3 ATRX ORC3 ITPR2 FXR1 NF1 MAGED2 RRP12 CTNND1 CDC27 MED12 | 5.51e-04 | 628 | 108 | 11 | int:SIRT6 |
| Interaction | BYSL interactions | 5.53e-04 | 346 | 108 | 8 | int:BYSL | |
| Interaction | KPNA1 interactions | 6.07e-04 | 351 | 108 | 8 | int:KPNA1 | |
| Interaction | MYOD1 interactions | 6.25e-04 | 194 | 108 | 6 | int:MYOD1 | |
| Interaction | DAXX interactions | 6.30e-04 | 353 | 108 | 8 | int:DAXX | |
| Interaction | SIRT7 interactions | SART3 KIF1A ESR1 SPTBN1 FXR1 NF1 RRP12 MACF1 NIPBL FKBP4 MED12 XPO7 | 6.39e-04 | 744 | 108 | 12 | int:SIRT7 |
| Interaction | RHOA interactions | VEZT ESR1 SPTBN1 CLIP1 AKAP12 ITPR2 PTPN2 FXR1 KIDINS220 NF1 RRP12 MACF1 CTNND1 ACBD3 ARHGAP21 SLC26A6 | 6.40e-04 | 1199 | 108 | 16 | int:RHOA |
| Interaction | CDC42 interactions | VEZT SEPTIN9 ESR1 SPTBN1 PRRT2 CLIP1 STAT1 AKAP12 ITPR2 TBC1D8 PTPN2 KIDINS220 NF1 CTNND1 ACBD3 ARHGAP21 SLC26A6 | 6.55e-04 | 1323 | 108 | 17 | int:CDC42 |
| Interaction | SNW1 interactions | ATRX ORC3 SEPTIN9 ESR1 SPTBN1 SRP54 IKZF1 FXR1 MAGED2 USO1 CDC27 NIPBL | 6.62e-04 | 747 | 108 | 12 | int:SNW1 |
| Interaction | FKBP1B interactions | 6.63e-04 | 32 | 108 | 3 | int:FKBP1B | |
| Interaction | CIT interactions | ORC3 HIPK1 SEPTIN9 ESR1 SPTBN1 CD109 SRP54 RNF213 POTEKP STAT3 FXR1 MAGED2 RRP12 MACF1 BOD1L1 CTNND1 NIPBL CCSER1 | 6.71e-04 | 1450 | 108 | 18 | int:CIT |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 7.01e-06 | 29 | 78 | 4 | 396 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.50e-05 | 3 | 78 | 2 | 287 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 1.10e-04 | 4 | 78 | 2 | 1184 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.03e-03 | 46 | 78 | 3 | 622 | |
| GeneFamily | LIM domain containing | 2.11e-03 | 59 | 78 | 3 | 1218 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP100 ATRX SEPTIN9 ZMYM2 INPP5F CLIP1 CREB1 PTPN2 FXR1 KIDINS220 ARNT2 NAV3 MACF1 CDC27 ACBD3 NIPBL | 4.48e-07 | 856 | 108 | 16 | M4500 |
| Coexpression | TRAYNOR_RETT_SYNDROM_UP | 6.35e-07 | 40 | 108 | 5 | M2712 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 8.66e-07 | 181 | 108 | 8 | M39225 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 7.99e-06 | 174 | 108 | 7 | M6881 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 8.61e-06 | 176 | 108 | 7 | M8248 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 1.79e-05 | 197 | 108 | 7 | M3133 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.97e-05 | 200 | 108 | 7 | M8959 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SP100 AHI1 ESR1 CD109 REL INPP5F GRHL2 STAT1 ATP2C2 PRICKLE2 PLCB1 MACF1 FOXP1 | 2.15e-05 | 786 | 108 | 13 | M10961 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX SEPTIN9 ZMYM2 INPP5F CLIP1 CREB1 PTPN2 FXR1 LIMCH1 CDC27 | 2.35e-05 | 466 | 108 | 10 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANK2 ATRX KIF1A PRRT2 CLIP1 DSCAML1 RYR2 SEMA3A ZNF462 ARNT2 PRICKLE2 NAV3 KDM2B BOD1L1 CCSER1 | 4.83e-05 | 1106 | 108 | 15 | M39071 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ATRX ORC3 SRP54 CLIP1 STAT1 AKAP12 KIDINS220 USO1 LZTS1 ARIH2 ARNT2 PLCB1 ATP1A2 CDC27 YIPF3 XPO7 | 5.18e-05 | 1248 | 108 | 16 | M17728 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | CLDN18 AHI1 ANK2 KIF1A IKZF1 POTEKP ZNF462 KIDINS220 TMEM132D PXDNL FOXP1 LIMCH1 CCSER1 | 6.32e-05 | 873 | 108 | 13 | M16009 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 7.31e-05 | 169 | 108 | 6 | M39230 | |
| Coexpression | KOHN_EMT_EPITHELIAL | 9.90e-05 | 22 | 108 | 3 | M46416 | |
| Coexpression | GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 1.47e-04 | 192 | 108 | 6 | M4689 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN | 1.47e-04 | 192 | 108 | 6 | M6064 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | CLDN18 SP100 HIPK1 SRP54 BCL7A CLIP1 STAT1 AKAP12 KIDINS220 USO1 NFYB | 1.60e-04 | 705 | 108 | 11 | M1410 |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.69e-04 | 197 | 108 | 6 | M9862 | |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN | 1.74e-04 | 198 | 108 | 6 | M7916 | |
| Coexpression | GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 1.74e-04 | 198 | 108 | 6 | M4249 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 1.79e-04 | 199 | 108 | 6 | M5368 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_DN | 1.79e-04 | 199 | 108 | 6 | M5439 | |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_DN | 1.79e-04 | 199 | 108 | 6 | M4127 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M5087 | |
| Coexpression | GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M6475 | |
| Coexpression | GSE16385_MONOCYTE_VS_MACROPHAGE_DN | 1.84e-04 | 200 | 108 | 6 | M7901 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 1.84e-04 | 200 | 108 | 6 | M7909 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M2936 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP | 1.84e-04 | 200 | 108 | 6 | M6558 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 1.84e-04 | 200 | 108 | 6 | M7891 | |
| Coexpression | GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN | 1.84e-04 | 200 | 108 | 6 | M3411 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 1.84e-04 | 200 | 108 | 6 | M7289 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.84e-04 | 200 | 108 | 6 | M8614 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN | 1.84e-04 | 200 | 108 | 6 | M9285 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | SART3 ATRX SRP54 IKZF1 TFG STAT3 ITPR2 EIF2D BRD8 ARIH2 NFYB CTNND1 CDC27 ACBD3 FKBP4 MED12 | 1.95e-04 | 1399 | 108 | 16 | M535 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.99e-04 | 289 | 108 | 7 | M2196 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 2.06e-04 | 130 | 108 | 5 | M6590 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 2.73e-04 | 404 | 108 | 8 | M19488 | |
| Coexpression | MAHAJAN_RESPONSE_TO_IL1A_UP | 2.93e-04 | 77 | 108 | 4 | M6154 | |
| Coexpression | KRAS.300_UP.V1_UP | 3.20e-04 | 143 | 108 | 5 | M2875 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.20e-04 | 143 | 108 | 5 | M9149 | |
| Coexpression | BENPORATH_CYCLING_GENES | AHI1 ORC3 KIAA0586 STAT1 BRD8 FXR1 SLC4A1AP CTNND1 CDC27 NIPBL | 3.51e-04 | 648 | 108 | 10 | M8156 |
| Coexpression | IBRAHIM_NRF1_UP | 3.54e-04 | 420 | 108 | 8 | M42509 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 3.71e-04 | 34 | 108 | 3 | M1906 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | AHI1 ORC3 CLIP1 CREB1 STAT1 ITPR2 FXR1 KIDINS220 SLC4A1AP NIPBL | 3.86e-04 | 656 | 108 | 10 | M18979 |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_UP | 3.87e-04 | 149 | 108 | 5 | M393 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.89e-04 | 323 | 108 | 7 | M9150 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATRX HIPK1 SEPTIN9 RNF213 IKZF1 CLIP1 CREB1 CDC14A STAT1 STAT3 ITPR2 PTPN2 KIDINS220 MACF1 BOD1L1 NIPBL | 3.99e-04 | 1492 | 108 | 16 | M40023 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | AHI1 ANK2 SPTBN1 CLIP1 STAT1 ITPR2 PTPN2 NF1 LZTS1 MACF1 CDC27 | 4.22e-04 | 790 | 108 | 11 | M12490 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 4.23e-04 | 152 | 108 | 5 | M39243 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 4.27e-04 | 85 | 108 | 4 | M12924 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 AHI1 ANK2 ATRX KIF1A PTBP2 ORC3 KIAA0586 MYRIP ZMYM2 TFG CLIP1 CDC14A ZNF462 ATP2C2 ARNT2 MACF1 BOD1L1 NIPBL MYB | 2.95e-07 | 1060 | 107 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.85e-07 | 193 | 107 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 SP100 AHI1 ANK2 ATRX KIF1A PTBP2 ORC3 KIAA0586 MYRIP ZMYM2 TFG CLIP1 CDC14A DSCAML1 ZNF462 ATP2C2 ARNT2 MACF1 BOD1L1 NIPBL MYB | 1.80e-06 | 1414 | 107 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 ATRX PTBP2 ORC3 ZGRF1 KIAA0586 ZMYM2 TFG CLIP1 PTPN2 MACF1 BOD1L1 ACBD3 NIPBL | 3.34e-06 | 629 | 107 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | AHI1 ATRX PTBP2 KIAA0586 ZMYM2 CLIP1 PANK1 BOD1L1 NIPBL ARHGAP21 | 3.94e-06 | 311 | 107 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.86e-06 | 192 | 107 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280 | 6.79e-06 | 260 | 107 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | SPATA7 SP100 ATRX PTBP2 KIAA0586 CLIP1 MACF1 LIMCH1 MME ACBD3 NIPBL CCSER1 | 7.07e-06 | 492 | 107 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 AHI1 ATRX KIF1A ORC3 ZGRF1 KIAA0586 INPP5F TFG CLIP1 MACF1 BOD1L1 ACBD3 | 9.37e-06 | 595 | 107 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | AHI1 ANK2 ATRX KIF1A PTBP2 ORC3 ZGRF1 KIAA0586 ZMYM2 CLIP1 CDC14A ZNF462 SLC4A1AP MACF1 BOD1L1 CDC27 NIPBL ARHGAP21 CCSER1 | 1.53e-05 | 1257 | 107 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | GPR17 ANK2 PRICKLE1 PTBP2 MYRIP RYR2 RYR3 SEMA3A ZNF462 PTPN2 KCNA1 PLCB1 LIMCH1 MME CCSER1 | 1.70e-05 | 827 | 107 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 SART3 SP100 AHI1 ATRX KIF1A PTBP2 POGK KIAA0586 ZMYM2 IKZF1 CLIP1 PANK1 BOD1L1 NIPBL ARHGAP21 | 3.50e-05 | 989 | 107 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SPATA7 SP100 ATRX PTBP2 ZMYM2 RNF213 IKZF1 GRHL2 CLIP1 UCMA ZNF462 MACF1 BOD1L1 LIMCH1 ACBD3 NIPBL | 3.50e-05 | 989 | 107 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | AHI1 ANK2 ATRX KIF1A PTBP2 ORC3 ZGRF1 KIAA0586 ZMYM2 CLIP1 CDC14A ZNF462 SLC4A1AP MACF1 BOD1L1 CDC27 NIPBL ARHGAP21 MYB CCSER1 | 3.62e-05 | 1459 | 107 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 4.66e-05 | 78 | 107 | 5 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 ATRX PTBP2 ZMYM2 RNF213 CLIP1 UCMA MACF1 BOD1L1 NIPBL | 6.64e-05 | 432 | 107 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 6.85e-05 | 137 | 107 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SART3 AHI1 ATRX PTBP2 POGK HIPK1 KIAA0586 ZMYM2 CLIP1 PANK1 SLC4A1AP BOD1L1 NIPBL ARHGAP21 | 7.36e-05 | 831 | 107 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.65e-05 | 203 | 107 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | GPR17 ANK2 PRICKLE1 VEZT POGK CD109 SEMA3A ZNF462 ARNT2 FOXP1 LIMCH1 MME MYB XPO7 | 9.36e-05 | 850 | 107 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.14e-04 | 291 | 107 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 1.22e-04 | 152 | 107 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SPATA7 ATRX ORC3 ZGRF1 KIAA0586 TFG CLIP1 ITPR2 PTPN2 MACF1 ACBD3 | 1.31e-04 | 564 | 107 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.57e-04 | 305 | 107 | 8 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.62e-04 | 229 | 107 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_100 | 2.05e-04 | 23 | 107 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AHI1 ANK2 ATRX VEZT PTBP2 MYRIP RYR2 RYR3 ZNF462 ARNT2 PLCB1 MME CCSER1 | 2.40e-04 | 818 | 107 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_100 | 2.97e-04 | 26 | 107 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | AHI1 SRP54 RNF213 IKZF1 UCMA ITPR2 ZNF462 NAV3 PLCB1 MACF1 BOD1L1 LIMCH1 MME CCSER1 | 3.96e-04 | 978 | 107 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SP100 AHI1 ATRX KIF1A PTBP2 KIAA0586 PRRT2 GRHL2 CLIP1 ZNF462 PRICKLE2 MACF1 PPIP5K1 NIPBL | 4.30e-04 | 986 | 107 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | AHI1 ANK2 ATRX KIF1A PTBP2 KIAA0586 MYRIP ZMYM2 BCL7A CLIP1 CDC14A ZNF462 ARNT2 KDM2B BOD1L1 NIPBL ARHGAP21 | 4.83e-04 | 1370 | 107 | 17 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | ATRX ESR1 SPTBN1 MYRIP RNF213 CDC14A STAT3 RYR2 ITPR2 MAGED2 ATP2C2 CCSER1 | 5.02e-04 | 770 | 107 | 12 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 ATRX PTBP2 HIPK1 KIAA0586 ZMYM2 CLIP1 PANK1 SLC4A1AP MACF1 ACBD3 NIPBL | 5.63e-04 | 780 | 107 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATRX ESR1 SPTBN1 KIAA0586 RNF213 IKZF1 INPP5F PANK1 CDC14A STAT3 RYR2 ITPR2 | 6.66e-04 | 795 | 107 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 7.43e-04 | 385 | 107 | 8 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-11 | 184 | 109 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-10 | 182 | 109 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-10 | 185 | 109 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.12e-08 | 188 | 109 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.30e-08 | 199 | 109 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.43e-08 | 200 | 109 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.43e-08 | 200 | 109 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.43e-08 | 200 | 109 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.43e-08 | 200 | 109 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-07 | 176 | 109 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-07 | 179 | 109 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-07 | 182 | 109 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-07 | 182 | 109 | 7 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-07 | 186 | 109 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.77e-07 | 192 | 109 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-07 | 195 | 109 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.67e-07 | 197 | 109 | 7 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.67e-07 | 197 | 109 | 7 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-07 | 198 | 109 | 7 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-07 | 198 | 109 | 7 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.06e-07 | 199 | 109 | 7 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.06e-07 | 199 | 109 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.06e-07 | 199 | 109 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 6.06e-07 | 199 | 109 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.27e-07 | 200 | 109 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-07 | 200 | 109 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.27e-07 | 200 | 109 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.27e-07 | 200 | 109 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 6.27e-07 | 200 | 109 | 7 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 6.27e-07 | 200 | 109 | 7 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 136 | 109 | 6 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.21e-06 | 154 | 109 | 6 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.38e-06 | 156 | 109 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.66e-06 | 159 | 109 | 6 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.86e-06 | 161 | 109 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 163 | 109 | 6 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 163 | 109 | 6 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.04e-06 | 171 | 109 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-06 | 175 | 109 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-06 | 176 | 109 | 6 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 178 | 109 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 182 | 109 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 182 | 109 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-06 | 183 | 109 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 183 | 109 | 6 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 183 | 109 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 183 | 109 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 183 | 109 | 6 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-06 | 184 | 109 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.16e-06 | 184 | 109 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-06 | 185 | 109 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-06 | 187 | 109 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.96e-06 | 188 | 109 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-06 | 188 | 109 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.96e-06 | 188 | 109 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.18e-06 | 189 | 109 | 6 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.40e-06 | 190 | 109 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.62e-06 | 191 | 109 | 6 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-06 | 191 | 109 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.62e-06 | 191 | 109 | 6 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-06 | 191 | 109 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 192 | 109 | 6 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-06 | 192 | 109 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 192 | 109 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 192 | 109 | 6 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.09e-06 | 193 | 109 | 6 | 89c63dd5d97fbd92ea308405b7e8e630dda5158d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 8.09e-06 | 193 | 109 | 6 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.09e-06 | 193 | 109 | 6 | 7842f29c16fe3a289ed3861fa570430142d2363f | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.33e-06 | 194 | 109 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 194 | 109 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 194 | 109 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.33e-06 | 194 | 109 | 6 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 194 | 109 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.33e-06 | 194 | 109 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.33e-06 | 194 | 109 | 6 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 109 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.58e-06 | 195 | 109 | 6 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.58e-06 | 195 | 109 | 6 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 109 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 109 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.83e-06 | 196 | 109 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.83e-06 | 196 | 109 | 6 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.09e-06 | 197 | 109 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.09e-06 | 197 | 109 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.63e-06 | 199 | 109 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-06 | 199 | 109 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 9.63e-06 | 199 | 109 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-06 | 199 | 109 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.63e-06 | 199 | 109 | 6 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-06 | 199 | 109 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.63e-06 | 199 | 109 | 6 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-06 | 199 | 109 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 9.63e-06 | 199 | 109 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.91e-06 | 200 | 109 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 109 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.36e-05 | 139 | 109 | 5 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | SP100 AHI1 KIAA0586 ZMYM2 PHLDB1 NF1 ARIH2 ATP2C2 TTC17 MED12 | 3.31e-08 | 196 | 108 | 10 | 7424_DN |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 4.42e-07 | 198 | 108 | 9 | 2640_DN | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.55e-06 | 182 | 108 | 8 | 4376_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 3.79e-06 | 192 | 108 | 8 | 2766_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 3.94e-06 | 193 | 108 | 8 | 7490_UP | |
| Drug | A25618 | SP100 ESR1 REL IKZF1 CREB1 STAT1 AKAP12 STAT3 SEMA3A BRD8 FXR1 LZTS1 NFYB FOXP1 MED12 | 3.98e-06 | 777 | 108 | 15 | CID000005562 |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 4.09e-06 | 194 | 108 | 8 | 7558_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.25e-06 | 195 | 108 | 8 | 5313_UP | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.25e-06 | 195 | 108 | 8 | 3451_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.25e-06 | 195 | 108 | 8 | 3835_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 3750_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 4715_UP | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 6605_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 4077_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | 4.93e-06 | 199 | 108 | 8 | 1960_DN | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.12e-06 | 200 | 108 | 8 | 5862_DN | |
| Drug | DNA methyltransferase inhibitor | 1.14e-05 | 160 | 108 | 7 | CID000344265 | |
| Drug | panobinostat | PRUNE2 MACC1 ZMYM2 GRHL2 AKAP12 STAT3 RYR3 ITPR2 TBC1D8 ZNF462 GRHL1 NF1 LZTS1 ATP2C2 ARNT2 KCNK10 NAV3 LIMCH1 VGLL1 | 1.52e-05 | 1333 | 108 | 19 | ctd:C496932 |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.83e-05 | 172 | 108 | 7 | 6989_UP | |
| Drug | Ryanodine | 2.21e-05 | 12 | 108 | 3 | ctd:D012433 | |
| Drug | 1a-h | 2.23e-05 | 2 | 108 | 2 | CID011513133 | |
| Drug | 2a-h | 2.23e-05 | 2 | 108 | 2 | CID011650493 | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 2.82e-05 | 184 | 108 | 7 | 2691_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.92e-05 | 185 | 108 | 7 | 1673_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.23e-05 | 188 | 108 | 7 | 4835_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 3.57e-05 | 191 | 108 | 7 | 1706_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.82e-05 | 193 | 108 | 7 | 3209_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.82e-05 | 193 | 108 | 7 | 3841_DN | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 5328_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 2293_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 4387_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 108 | 7 | 5457_DN | |
| Drug | 5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.08e-05 | 195 | 108 | 7 | 920_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 5004_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 6176_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 3459_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 1532_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.08e-05 | 195 | 108 | 7 | 4961_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 5425_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 6619_DN | |
| Drug | Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 3475_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 7321_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 1708_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 4583_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 2343_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 4764_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 5453_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 3301_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 2368_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 6292_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 6681_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 5487_DN | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 5864_DN | |
| Drug | CP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 7515_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 3756_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 1694_UP | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 1705_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 4.64e-05 | 199 | 108 | 7 | 346_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 6765_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A | 4.64e-05 | 199 | 108 | 7 | 2012_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HG-U133A | 4.64e-05 | 199 | 108 | 7 | 1918_DN | |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; MCF7; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 3481_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 4.79e-05 | 200 | 108 | 7 | 1592_DN | |
| Drug | Thimerosal | ANK2 ATRX KIF1A PTBP2 SEPTIN9 SPTBN1 IKZF1 CTXN3 CREB1 RYR3 NF1 NFYB NAV3 BOD1L1 CDC27 NIPBL CCSER1 | 4.83e-05 | 1199 | 108 | 17 | ctd:D013849 |
| Drug | cis-diammineplatinum(II | 6.67e-05 | 3 | 108 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.67e-05 | 3 | 108 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 6.67e-05 | 3 | 108 | 2 | CID000127713 | |
| Drug | aminodantrolene | 6.67e-05 | 3 | 108 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.67e-05 | 3 | 108 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.67e-05 | 3 | 108 | 2 | CID005748312 | |
| Drug | rotundifuran | 6.67e-05 | 3 | 108 | 2 | CID005315261 | |
| Drug | tetrachlorobisphenol A | 6.72e-05 | 17 | 108 | 3 | CID000006619 | |
| Drug | PCB 104 | 6.72e-05 | 17 | 108 | 3 | CID000091662 | |
| Drug | CV-1 | 7.12e-05 | 213 | 108 | 7 | CID000130105 | |
| Drug | lead compounds | 8.14e-05 | 150 | 108 | 6 | CID000073212 | |
| Drug | testosterone enanthate | PRUNE2 SART3 ATRX HIPK1 ESR1 CREB1 STAT1 FXR1 MACF1 ACBD3 FKBP4 | 9.15e-05 | 575 | 108 | 11 | ctd:C004648 |
| Drug | NSC717865 | 9.60e-05 | 387 | 108 | 9 | CID000005372 | |
| Drug | oxybenzone | 1.09e-04 | 52 | 108 | 4 | ctd:C005290 | |
| Drug | AC1L9K70 | 1.09e-04 | 228 | 108 | 7 | CID000446871 | |
| Drug | WHI-P97 | 1.12e-04 | 20 | 108 | 3 | CID000003796 | |
| Drug | CGP7040 | 1.12e-04 | 20 | 108 | 3 | CID006436259 | |
| Drug | tamibarotene | ATRX HIPK1 ESR1 IKZF1 BCL7A CREB1 STAT1 ITPR2 NFYB MACF1 MYB | 1.25e-04 | 596 | 108 | 11 | ctd:C061133 |
| Drug | NSC 89199 | 1.26e-04 | 54 | 108 | 4 | CID000003268 | |
| Drug | KB-141 | 1.33e-04 | 4 | 108 | 2 | CID009863447 | |
| Drug | PCB74 | 1.33e-04 | 4 | 108 | 2 | CID000036218 | |
| Drug | peroxyvanadate | 1.33e-04 | 4 | 108 | 2 | ctd:C500599 | |
| Drug | 148504-47-6 | 1.33e-04 | 4 | 108 | 2 | CID006444275 | |
| Drug | SC 38249 | 1.33e-04 | 4 | 108 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.33e-04 | 4 | 108 | 2 | CID000035682 | |
| Drug | O-Ir | 1.56e-04 | 57 | 108 | 4 | CID000448249 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.78e-04 | 173 | 108 | 6 | 2084_DN | |
| Drug | DITPA | 1.95e-04 | 24 | 108 | 3 | CID000160565 | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 2.01e-04 | 177 | 108 | 6 | 4590_UP | |
| Drug | Polychlorinated Biphenyls | SP100 ATRX PTBP2 ESR1 RNF213 PRRT2 AKAP12 MACF1 FOXP1 FKBP4 MYB | 2.11e-04 | 633 | 108 | 11 | ctd:D011078 |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.14e-04 | 179 | 108 | 6 | 4619_UP | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.14e-04 | 179 | 108 | 6 | 4554_DN | |
| Drug | 2,3',5,5'-tetrachlorobiphenyl | 2.21e-04 | 5 | 108 | 2 | CID000038878 | |
| Drug | 4-hydroxy-2,2',5,5'-tetrachlorobiphenyl | 2.21e-04 | 5 | 108 | 2 | CID000039971 | |
| Drug | Naloxone | 2.21e-04 | 5 | 108 | 2 | DB01183 | |
| Drug | 4-ethoxymethylphenol | 2.21e-04 | 5 | 108 | 2 | CID000093781 | |
| Disease | Malignant neoplasm of breast | ANK2 ESR1 CD109 CLIP1 STAT1 AKAP12 STAT3 SEMA3A FXR1 NF1 MAGED2 PLCB1 MACF1 BOD1L1 MME CLUL1 CDC27 NIPBL MED12 | 1.20e-08 | 1074 | 108 | 19 | C0006142 |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.02e-05 | 12 | 108 | 3 | DOID:3319 (is_marker_for) | |
| Disease | Paroxysmal kinesigenic choreoathetosis | 1.33e-05 | 2 | 108 | 2 | C1868682 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | testosterone measurement | ANK2 SEPTIN9 ESR1 CREB1 TBC1D8 SEMA3A NF1 SLC4A1AP PLCB1 MACF1 FOXP1 MME ARHGAP21 FKBP4 MED12 | 6.35e-05 | 1275 | 108 | 15 | EFO_0004908 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 8.20e-05 | 194 | 108 | 6 | EFO_0004265, EFO_0007908 | |
| Disease | breast carcinoma (is_implicated_in) | 1.03e-04 | 25 | 108 | 3 | DOID:3459 (is_implicated_in) | |
| Disease | retinal vasculature measurement | SEPTIN9 SPTBN1 DSCAML1 TMEM132D LZTS1 NAV3 PLCB1 CLUL1 CCSER1 | 1.22e-04 | 517 | 108 | 9 | EFO_0010554 |
| Disease | Malignant Glioma | 1.29e-04 | 70 | 108 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.29e-04 | 70 | 108 | 4 | C0259783 | |
| Disease | JOUBERT SYNDROME 17 | 1.32e-04 | 5 | 108 | 2 | C3553264 | |
| Disease | angiomyolipoma (is_marker_for) | 1.32e-04 | 5 | 108 | 2 | DOID:3314 (is_marker_for) | |
| Disease | Leukemia, T-Cell | 1.32e-04 | 5 | 108 | 2 | C0023492 | |
| Disease | obesity (implicated_via_orthology) | 1.44e-04 | 215 | 108 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | neutrophil count | PRUNE2 AHI1 SEPTIN9 SPTBN1 IKZF1 CDC14A AKAP12 ITPR2 TBC1D8 KIDINS220 RRP12 PLCB1 FOXP1 ACBD3 MYB | 1.55e-04 | 1382 | 108 | 15 | EFO_0004833 |
| Disease | Profound Mental Retardation | 1.63e-04 | 139 | 108 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.63e-04 | 139 | 108 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.63e-04 | 139 | 108 | 5 | C0917816 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 1.97e-04 | 6 | 108 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | Familial benign neonatal epilepsy | 1.97e-04 | 6 | 108 | 2 | C0220669 | |
| Disease | Intellectual Disability | 2.45e-04 | 447 | 108 | 8 | C3714756 | |
| Disease | neutropenia (implicated_via_orthology) | 2.75e-04 | 7 | 108 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 2.75e-04 | 7 | 108 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | Glioma | 2.99e-04 | 87 | 108 | 4 | C0017638 | |
| Disease | epilepsy (implicated_via_orthology) | 3.41e-04 | 163 | 108 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | sleep apnea | 4.27e-04 | 40 | 108 | 3 | EFO_0003877 | |
| Disease | platelet component distribution width | 4.61e-04 | 755 | 108 | 10 | EFO_0007984 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 4.70e-04 | 9 | 108 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | PR interval | 4.82e-04 | 495 | 108 | 8 | EFO_0004462 | |
| Disease | Hypermetropia | 5.68e-04 | 103 | 108 | 4 | HP_0000540 | |
| Disease | interventricular septum thickness | 5.86e-04 | 10 | 108 | 2 | EFO_0009287 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 5.86e-04 | 10 | 108 | 2 | C1631597 | |
| Disease | selective IgA deficiency disease | 6.46e-04 | 46 | 108 | 3 | EFO_1001929 | |
| Disease | serum IgG measurement, response to dietary antigen | 7.14e-04 | 11 | 108 | 2 | EFO_0004565, EFO_0005844 | |
| Disease | taurodeoxycholate measurement | 8.55e-04 | 12 | 108 | 2 | EFO_0010539 | |
| Disease | nervous system disease (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Oligospermia | 8.55e-04 | 12 | 108 | 2 | C0028960 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.55e-04 | 12 | 108 | 2 | C0023485 | |
| Disease | optic disc size measurement | 9.63e-04 | 205 | 108 | 5 | EFO_0004832 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.78e-04 | 53 | 108 | 3 | C1961099 | |
| Disease | velocity of sound measurement | 1.01e-03 | 13 | 108 | 2 | EFO_0005654 | |
| Disease | Migraine Disorders | 1.01e-03 | 13 | 108 | 2 | C0149931 | |
| Disease | illegal drug consumption | 1.01e-03 | 13 | 108 | 2 | EFO_0005431 | |
| Disease | leukemia | 1.09e-03 | 55 | 108 | 3 | C0023418 | |
| Disease | eating disorder, bipolar disorder | 1.17e-03 | 14 | 108 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.21e-03 | 57 | 108 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Ulcerative Colitis | 1.61e-03 | 63 | 108 | 3 | C0009324 | |
| Disease | reticulocyte measurement | SEPTIN9 IKZF1 CLIP1 TSEN2 STAT1 TBC1D8 PLCB1 FOXP1 CTNND1 ARHGAP21 MED12 | 1.67e-03 | 1053 | 108 | 11 | EFO_0010700 |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.69e-03 | 64 | 108 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | Headache | 1.69e-03 | 64 | 108 | 3 | HP_0002315 | |
| Disease | Moyamoya Disease | 1.74e-03 | 17 | 108 | 2 | C0026654 | |
| Disease | acute lymphoblastic leukemia | 1.85e-03 | 66 | 108 | 3 | EFO_0000220 | |
| Disease | Malignant neoplasm of liver | 1.87e-03 | 142 | 108 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.87e-03 | 142 | 108 | 4 | C0023903 | |
| Disease | diffuse plaque measurement | 1.89e-03 | 758 | 108 | 9 | EFO_0010699 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 1.95e-03 | 18 | 108 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | urate measurement, bone density | 2.01e-03 | 619 | 108 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Usual Interstitial Pneumonia | 2.18e-03 | 19 | 108 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.18e-03 | 19 | 108 | 2 | C4721508 | |
| Disease | Cannabis use, age at onset | 2.18e-03 | 19 | 108 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.40e-03 | 152 | 108 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | BRCAX breast cancer | 2.42e-03 | 20 | 108 | 2 | EFO_0009443 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.42e-03 | 20 | 108 | 2 | C4721952 | |
| Disease | cortical thickness | PTBP2 SPTBN1 STAT1 UCMA SEMA3A ZNF462 PHLDB1 NAV3 MACF1 FOXP1 ARHGAP21 | 2.57e-03 | 1113 | 108 | 11 | EFO_0004840 |
| Disease | platelet crit | 2.61e-03 | 952 | 108 | 10 | EFO_0007985 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.66e-03 | 75 | 108 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.66e-03 | 21 | 108 | 2 | C1292769 | |
| Disease | Joubert syndrome 1 | 2.66e-03 | 21 | 108 | 2 | C4551568 | |
| Disease | cytotoxicity measurement, response to metformin | 2.66e-03 | 21 | 108 | 2 | EFO_0006952, GO_1901558 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.66e-03 | 21 | 108 | 2 | C1800706 | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.66e-03 | 21 | 108 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.19e-03 | 80 | 108 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | malignant astrocytoma (is_marker_for) | 3.19e-03 | 23 | 108 | 2 | DOID:3069 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 3.23e-03 | 525 | 108 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.23e-03 | 525 | 108 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 3.30e-03 | 527 | 108 | 7 | C1458155 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSETQNSTSQKAMDE | 1 | Q86UN6 | |
| EKGSVQMDSTLQGDM | 201 | P41214 | |
| NESADSSMSLEQKMT | 16 | Q4LDR2 | |
| TTMEEATSGVNESEM | 206 | Q9H0E9 | |
| GSESMTHSEMRKEQS | 1156 | Q8N157 | |
| TESTASEMQEEMKGS | 646 | Q02952 | |
| DMSIGGNLSKTQNME | 361 | Q9UNH5 | |
| LDSEQEMAMAASSSS | 221 | Q9BYX7 | |
| EMLKLSGSDSSQSMN | 16 | Q13304 | |
| MSVDMNSQGSDSNEE | 1 | O95376 | |
| DSVSEMDAFSKSGSM | 266 | Q9C0I3 | |
| MGQTGTDVSKEAANM | 691 | O75185 | |
| TMDSENANSDMDKGQ | 26 | Q5SZJ8 | |
| EKKMMSSASAAGTQQ | 506 | Q9HBZ2 | |
| ENMGAVDSADQMLTS | 426 | Q96DM1 | |
| TGLSSKMQDTMEENS | 331 | P17706 | |
| SGQDSDKMGISMSDI | 1731 | Q14571 | |
| MMNEDAAQKSDSGEK | 1 | Q01484 | |
| TAETNMGTTNSMHKL | 6011 | Q8WXI7 | |
| AMGADVDQEGANSMT | 191 | Q9ULH0 | |
| MTVMSGENVDEASAA | 1 | Q09470 | |
| DSNMMSLKALSFSDG | 221 | Q9Y250 | |
| AEASEKDSSSMMQTL | 16 | Q9UNF1 | |
| DMAQVNMSTDLEGTD | 466 | Q86Z02 | |
| NMSTDLEGTDMLAEK | 471 | Q86Z02 | |
| DQGTTDTMATDQTML | 461 | Q17R60 | |
| VLMDGMTESDTASVN | 516 | P51114 | |
| ASTNDKGSMAMESAK | 166 | P03372 | |
| MSQIDMSEKASSDLD | 796 | Q8IVL0 | |
| MMQESGTETKSNGSA | 1 | Q9H334 | |
| MGKSESQMDITDINT | 1 | P08473 | |
| QEDLKEMGDVSSGMS | 2261 | Q6KC79 | |
| MTMDGDSSTTDASQL | 1 | P25208 | |
| TMEKMEGSTISSNGT | 61 | O94854 | |
| ADMSSISQGSMEENK | 1596 | Q93074 | |
| MMSVNGQAKTHTDSS | 331 | Q9H3P7 | |
| EKMCNSDNSSTAMLT | 491 | P57789 | |
| ASCGKMEEQMTSSSQ | 611 | P10242 | |
| MDADEGQDMSQVSGK | 1 | Q13422 | |
| HATDSVKNSMESMNT | 476 | Q9P215 | |
| MKDSGDSKDQQLMVA | 1 | Q2TAC6 | |
| TEDCEKMSNMGTLNS | 571 | Q96MT3 | |
| SKDSGMNVSEKLSNM | 576 | Q7Z3G6 | |
| MAASSSEISEMKGVE | 1 | Q7Z6L0 | |
| MARNSAGEAKTQSAM | 306 | A1KZ92 | |
| SISSEEVDGSQGNMM | 1701 | Q8NFC6 | |
| QMASAQKISRGSDMD | 336 | P0CF75 | |
| MGISGSDVSKQAADM | 731 | P50993 | |
| KISGSGSNSDMMENS | 46 | P46100 | |
| GSNSDMMENSKEEGT | 51 | P46100 | |
| MMENSKEEGTSSSEK | 56 | P46100 | |
| DEEMKNVMDSSNGLS | 296 | Q6YHK3 | |
| AATKAMMSINGDEDS | 46 | Q6ISB3 | |
| KAMMSINGDEDSAAA | 46 | Q9NZI5 | |
| MDVNTQKGTEMSMSQ | 141 | Q8NHM5 | |
| SDQMTTGTNENADSM | 1841 | Q8TD84 | |
| MTMESGAENQQSGDA | 1 | P16220 | |
| QSMSEANLIDMEAGK | 16 | Q6ZN28 | |
| MTAEEMKATESGAQS | 1 | Q02790 | |
| SSMEHSMNSSEKVDR | 156 | Q4VC05 | |
| ESQASQAVMKMDGMT | 851 | Q15020 | |
| KSDSSLETMENTGVM | 826 | Q9Y2H2 | |
| VSMMEKQSSMDSEGN | 2686 | Q92736 | |
| QIMGTDESQESSMTD | 796 | P30260 | |
| IGSMEDSAKANMTLT | 106 | P56856 | |
| FAKSDTSLEMTMGNA | 116 | P08185 | |
| EEIQMSNMGSNTKSL | 886 | O60716 | |
| AEIMKMSGDNSSQLT | 931 | P30622 | |
| MSGDNSSQLTKMNDE | 936 | P30622 | |
| MDSGNKARTVAATNM | 196 | Q12756 | |
| SSMTEGSGTMNKIDL | 846 | Q9UPQ0 | |
| SAVASSFGNMMSKEK | 491 | Q8TE04 | |
| KMDANSATSEEMNEI | 661 | Q9UBD5 | |
| MSEGNKSRTVAATNM | 201 | Q9NQT8 | |
| DKLNSGMVSNMEGTA | 151 | Q8NCE0 | |
| KDSMIENMKSSQTSG | 756 | O60763 | |
| GTDFMSKGNEQESMA | 356 | P61011 | |
| HTKVMNMEESTNGSL | 386 | P42224 | |
| TEDMTQKATDTGHMG | 631 | Q8WUY3 | |
| NMSSMVVTANGNDSK | 31 | Q9UKA9 | |
| MDGNDLMQASKGLSD | 901 | Q14C87 | |
| MQVSSGDKMEDATAN | 631 | Q9BXS9 | |
| NEGSSAMANGMEEKE | 566 | Q9UHD8 | |
| DDGDGSKTKEMSNSM | 681 | Q14563 | |
| SKAFMDIMSAQASSG | 191 | Q5JTH9 | |
| MAETVDTSEMVNGAT | 2141 | Q01082 | |
| GNISKQDETMMTDLS | 411 | Q15846 | |
| METTMGFMDDNATNT | 1 | Q8TCW9 | |
| NNNSTMASASEGEME | 36 | Q63HN8 | |
| DSSGKQSTQVMAASM | 151 | Q92734 | |
| SSMMAKSCQSGEDEE | 3581 | Q15413 | |
| TKVMNMEESNNGSLS | 391 | P40763 | |
| MMSSQNSEESEKEKS | 431 | O95759 | |
| ASDMMDTMDVENNST | 511 | P23497 | |
| SSGNTSQMSMDHEEL | 636 | P21359 | |
| ELGTAETKNMTDSEM | 286 | Q9P0W8 | |
| VNMMTTSSDSMGETD | 496 | Q04864 | |
| NMSSASGLDMGKIEE | 1136 | Q86UU1 | |
| GEDSSTSSMMSVNFD | 446 | Q96AE7 | |
| GSEAMATEEMSNLVN | 531 | Q9NQ66 | |
| MMSEDEGKTETTNIN | 956 | Q9UBW7 | |
| SAVIDMENMDDTSGS | 31 | Q9GZM5 | |
| DMISESKMDNESLNS | 501 | Q86YA3 | |
| DSMKNSTYGVNSNDM | 1071 | Q9UIA9 | |
| GMTDMTNSSADLETN | 366 | Q96JM2 | |
| SMNSDMGKVSKNDTE | 631 | Q9HBM0 | |
| AISSMQEELNKGMAD | 1191 | Q5T5U3 | |
| SSQSEGVMLKNDDSM | 61 | Q99990 | |
| ASSENEEMKTNQGSM | 931 | Q6PFW1 | |
| LSLSTMQEDMESSGA | 1516 | Q9BVV6 | |
| TMQMAGEEASEDAKQ | 31 | Q8WVF2 | |
| PSQDSLDAFMSEMKS | 531 | Q9BWU0 | |
| AMKMSEKETSSGEDQ | 591 | Q8NFW9 |